Subcellular localization of LKB1 and characterization of its interactions with the membrane skeleton in Drosophila melanogaster by Thiele, Christian Volker Steffen
  
 
 
Subcellular localization of LKB1 and 
characterization of its interactions 
with the membrane skeleton in 
Drosophila melanogaster   
 
DISSERTATION ZUR ERLANGUNG DES DOKTORGRADES 
DER NATURWISSENSCHAFTEN (DR. RER. NAT.) DER 
FAKULTÄT FÜR BIOLOGIE UND VORKLINISCHE 
MEDIZIN DER UNIVERSITÄT REGENSBURG 
 
vorgelegt von 
Christian Volker Steffen Thiele 
aus 
Osterode am Harz 
im Jahr 
2014
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Das Promotionsgesuch wurde eingereicht am: 
01.04.2014 
 
Die Arbeit wurde angeleitet von: 
Junior Prof. Dr. Dr. Michael Krahn 
 
Unterschrift: 
  
 
 
 
Contents 
1 Summary ........................................................................................................................................... 2 
2 Introduction ....................................................................................................................................... 3 
2.1 Cell polarity ................................................................................................ 3 
2.2 Drosophila cell types as a model for cell polarity ...................................... 3 
2.3 Epithelial cell polarity in vertebrates and Drosophila ................................ 4 
2.4 Drosophila neuronal stem cells (neuroblasts) as a model for asymmetric 
cell division and stem cell induced tumors ................................................. 5 
2.5 The PAR proteins ....................................................................................... 6 
2.6 LKB1 (STK11, PAR-4) is a multifunctional protein kinase with tumor 
suppressor activity ................................................................................................ 7 
2.6.1 The heterotrimeric complex LKB1-STRAD-Mo25 is the active unit of 
LKB1 .......................................................................................................... 8 
2.6.2 The LKB1-STRAD-Mo25 complex is probably conserved in lower model 
organisms .................................................................................................... 8 
2.6.3 Posttranslational modification and regulation of LKB1 activity ................ 9 
2.6.4 LKB1 in Drosophila ................................................................................. 10 
2.6.5 AMPK as a downstream target of LKB1.................................................. 11 
2.6.6 LKB1 in the regulation of cell polarity .................................................... 13 
2.6.7 Localization of LKB1 ............................................................................... 13 
2.6.8 The C-terminus of LKB1 is involved in membrane targeting of LKB1 .. 15 
2.6.9 Potential LKB1 interaction partners ......................................................... 17 
2.7 The membrane skeleton ............................................................................ 18 
2.7.1 Spectrin ..................................................................................................... 18 
3 Material and Methods .................................................................................................................... 20 
3.1 Material ..................................................................................................... 20 
3.1.1 Reagents ................................................................................................... 20 
3.1.2 Solutions ................................................................................................... 22 
3.1.3 Commercial kits ........................................................................................ 27 
  
 
BM Chemiluminescence Western Blotting Substrate (POD) ............................................................... 27 
QuikChange .............................................................................................................................................. 27 
3.1.4 Instruments and other material ................................................................. 27 
3.1.5 Antibodies ................................................................................................. 28 
1.1 MBP 7G4 .................................................................................................. 29 
3.1.6 Oligonucleotides ....................................................................................... 31 
3.1.7 Plasmids .................................................................................................... 35 
3.2 Molecular biology methods ...................................................................... 36 
3.2.1 Polymerase chain reaction (PCR) ............................................................. 36 
3.2.2 Agarose gel electrophoresis ...................................................................... 37 
3.2.3 Measurement of DNA concentration ........................................................ 37 
3.2.4 Gateway cloning ....................................................................................... 37 
3.2.5 pENTR/D-TOPO cloning ......................................................................... 38 
3.2.6 Cloning of potential LKB1 interaction partners ....................................... 38 
3.2.7 Cloning of lkb1::gfp-lkb1 genomic .......................................................... 38 
3.2.8 Gateway LR recombination reaction ........................................................ 39 
3.2.9 Transformation of chemically competent E. coli cells ............................. 40 
XL1-Blue 41 
Stratagene 41 
3.2.10 Isolation of plasmid DNA by Alkaline Lysis with SDS ........................... 41 
3.2.11 Site-directed mutagenesis ......................................................................... 42 
3.2.12 Sequencing of DNA ................................................................................. 43 
3.2.13 Isolation of genomic DNA from flies ....................................................... 44 
3.3 Drosophila cell culture ............................................................................. 44 
3.3.1 Culture and transfection of Schneider 2 cells ........................................... 44 
3.3.2 Leptomycin B assay ................................................................................. 45 
3.4 Histology .................................................................................................. 46 
3.4.1 Fixation and immunostaining of Schneider 2 cells .................................. 46 
  
 
3.4.2 Fixation and immunostaining of embryos ................................................ 46 
3.4.3 Fixation and immunostaining of ovaries .................................................. 47 
3.4.4 Fixation and immunostaining of larval brains and imaginal discs ........... 47 
3.4.5 Detection of apoptosis in imaginal discs .................................................. 48 
3.4.6 Confocal microscopy ................................................................................ 48 
3.4.7 Preparation and imaging of wings ............................................................ 48 
3.5 Biochemical methods ............................................................................... 49 
3.5.1 Protein extraction from embryos .............................................................. 49 
3.5.2 Measurement of protein concentration ..................................................... 49 
3.5.3 Co-Immunoprecipitation .......................................................................... 49 
3.5.4 SDS-polyacrylamide gel electrophoresis.................................................. 50 
3.5.5 Western Blot ............................................................................................. 51 
3.5.6 Protein purification ................................................................................... 51 
3.5.7 GST-Pulldown assay ................................................................................ 52 
3.5.8 Lipid overlay assay ................................................................................... 52 
3.6 Fly genetics ............................................................................................... 53 
3.6.1 Fly breeding .............................................................................................. 53 
3.6.2 Generation of transgenic flies ................................................................... 53 
3.6.3 The UAS-GAL4 system ........................................................................... 55 
3.6.4 FLP/FRT- mediated recombination .......................................................... 55 
3.6.5 Fly lines .................................................................................................... 56 
3.6.6 Lethality assay .......................................................................................... 60 
4 Results .............................................................................................................................................. 61 
4.1 Subcellular localization of LKB1 ............................................................. 61 
4.1.1 LKB1 localizes to the cortex of epithelial cells and embryonic neuroblasts
 61 
4.1.2 Farnesylation is not crucial for the cortical localization of LKB1 and its 
physiological function .............................................................................. 64 
  
 
4.1.3 Farnesylation of LKB1 is necessary for cortical localization of GFP-LKB1 
in S2R+ cells, but not sufficient ............................................................... 66 
4.1.4 A polybasic motif at the C-terminus targets LKB1 to the plasma 
membrane ................................................................................................. 67 
4.2 Investigation of α-Spectrin and β-Spectrin as potential interaction 
partners of LKB1 ........................................................................................................ 71 
4.2.1 The lipid binding domain of LKB1 is also involved in binding of α/β-
Spectrin ..................................................................................................... 71 
4.2.2 β-Spectrin is involved in lateral localization of LKB1 in follicle cells .... 73 
4.2.3 The N-terminus of β-Spectrin interacts with LKB1 ................................. 73 
4.3 Three NLS regulate nuclear localization of LKB1 ................................... 74 
4.3.1 Nuclear localization supports fertility and embryonic survival................ 75 
4.3.2 Nuclear localization signals are involved in the activation of AMPK ..... 75 
4.4 Effects of LKB1 overexpression .............................................................. 78 
4.4.1 LKB1 overexpression in embryonic neuroblasts and ubiquitous expression 
in the embryo lead to embryonic lethality independent of farnesylation, 
the lipid binding motif and kinase activity ............................................... 78 
4.4.2 LKB1 overexpression leads to a slight reduction of eye size dependent on 
kinase activity ........................................................................................... 80 
4.4.3 The reduction of wing size is minimized in the triple NLS mutant ......... 82 
4.5 Examination of phosphospecific antibodies against LKB1 ...................... 84 
5 Discussion ........................................................................................................................................ 86 
5.1 Cortical localization of LKB1 .................................................................. 87 
5.1.1 LKB1 localizes to the cortex of epithelial cells and embryonic neuroblasts
 87 
5.1.2 Farnesylation is not crucial for the cortical localization of LKB1 and its 
physiological function .............................................................................. 88 
5.1.3 Both farnesylation and a polybasic motif target LKB1 to the plasma 
membrane ................................................................................................. 89 
5.1.4 β-Spectrin is involved in lateral localization of LKB1 in follicle cells .... 91 
  
 
5.1.5 A functional role of LKB1 membrane localization .................................. 92 
5.2 Three NLS regulate nuclear localization of LKB1 ................................... 93 
5.3 Effect on mutations of LKB1 on AMPK activity ..................................... 94 
5.4 Kinase dependent and independent effects of overexpression of LKB1 .. 96 
6 References ........................................................................................................................................ 99 
7 Appendix ........................................................................................................................................ 114 
7.1 Table of Figures ...................................................................................... 114 
7.2 List of tables ........................................................................................... 115 
7.3 Abbreviations ......................................................................................... 116 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
1 
 
Danksagung 
 
Ich möchte mich bei allen bedanken, die mir in den letzten Jahren in Göttingen und 
Regensburg zur Seite standen.  
Ich danke Professor Michael Krahn für die Möglichkeit diese Promotion durchzuführen 
und die zahlreichen Anregungen, um dieses Projekt zu gestalten. 
Professor Witzgall und seinem Lehrstuhl danke ich für die Möglichkeiten, die uns sein 
Lehrstuhl geboten hat und seine interessanten und kritischen Fragen. 
I thank Arnab for all his help, patience and the company during our three years. 
Professor Sprenger und Professor Klein danke ich für ihre Rolle in meinem Mentoring 
Team.  
Ich möchte mich auch bei Florian, Gudrun, Laura und Giada bedanken für die 
gemeinsame Zeit und die gute Zusammenarbeit. 
Besonders möchte ich mich bei meiner Freundin Stefanie bedanken, die mich begleitet 
und unterstützt.  
 
 
 
 
 
 
 
 
 
Summary 
 
 
 
2 
 
1 Summary 
Germ line mutations in the human lkb1 gene are the main cause of the Peutz-Jeghers 
syndrome (Hemminki, 1999) and somatic lkb1 mutations are associated with mainly 
epithelial cancers (Sanchez-Cespedes, 2007). The serine/threonine kinase LKB1 
(STK11) is involved in different cellular processes like cell proliferation, energy 
homeostasis and cell polarity (Martin-Belmonte and Perez-Moreno, 2012). Especially 
the observation that activation of mammalian LKB1 can polarize cells in absence of 
cell-cell contacts (Baas et al., 2004) has drawn attention to the role of LKB1 in cell 
polarity. Using Drosophila melanogaster and other model organisms various potential 
downstream targets have been identified, while little is known about its upstream 
regulation and the mechanisms by which LKB1 controls cell polarity. It has been 
suggested that LKB1 might be mostly constitutively active and that its involvement in 
specific responses depends on localization of it to specific subcellular compartments 
(Sebbagh et al., 2011).  
In order to study the role of LKB1 in cell polarity an antibody against LKB1 has been 
raised for this work that could detect LKB1 in different tissue of Drosophila. 
Remarkably, endogenous LKB1 localizes cortically in asymmetrically dividing 
embryonic neuroblasts but cytoplasmic in larval neuroblasts. LKB1 has been described 
to control asymmetric divisions in both of these cell types. How it can exert its 
functions with different localizations remains to be answered. Furthermore, endogenous 
LKB1 localizes to the basolateral cortex in embryonic epithelial cells. I observed that a 
farnesylation deficiency does not alter the localization of LKB1 remarkably in epithelial 
cells and did not affect its activity towards its downstream target AMPK (AMP-
activated protein kinase). A polybasic motif was identified in this work, which interacts 
with phospholipids found in the plasma membrane and potentially with the newly 
identified interaction partners α-Spectrin and β-Spectrin. Furthermore, three nuclear 
localization signals (NLS) of Drosophila LKB1 were identified. A construct carrying 
mutations in all three NLS had a reduced ability to rescue an lkb1-KO mutant and 
revealed a lower basal activity towards its substrate AMPK in embryonic lysates. 
Moreover, the mutation of the three NLS decreased the phenotype of LKB1 
overexpression in the negative regulation of organ size compared to its wild type 
counterpart. 
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2 Introduction  
 
2.1 Cell polarity 
Cells in tissues of multicellular organisms, but also cells of single-cell organisms, show 
asymmetries in shape, protein and lipid distribution and cell function, defined as cell 
polarity. Polarization is initiated by either external or internal polarity cues. Contact to 
other cells or the extracellular matrix can, for example, serve as external cues for 
epithelial cells to form junctions and give rise to an epithelia tissue (Nelson, 2003). The 
establishment and maintenance of cell polarity is fundamentally important for diverse 
complex cellular functions, like formation of epithelial barriers, cell migration and 
asymmetric cell division. Most of the key components of cell polarity found in metazoa 
are well conserved throughout evolution.  
 
2.2  Drosophila cell types as a model for cell polarity 
Several cell types of Drosophila melanogaster have been established as model systems 
for in vivo studies on different aspects of cell polarity:  
- The oocyte, similar to the early Caenorhabditis elegans (C. elegans)  embryo, displays 
an anterior-posterior polarity. 
- The mesodermal follicle cell epithelium surrounding the egg chamber and the 
ectodermal epithelium surrounding the embryo. Both form monolayers of cuboidal 
polarized cells. A peculiarity of the follicle cells is that their apical side is not directed 
towards a lumen or the external environment, instead it forms cell-cell contacts with the 
germline cells.  
- Drosophila neuronal stem cells (neuroblasts) are a common model for studying 
asymmetric cell division.  
The use of Drosophila as a model system for cell polarity offers diverse tools to study 
mechanisms and effects of cell polarity in vivo. One important question for the 
understanding of tumor progression is, whether the loss of epithelial polarity observed 
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in cancer is an epiphenomenon or a cause of cancer (Partanen et al., 2013). Experiments 
in Drosophila suggest a causal role of polarity proteins in tumor progression (Bilder, 
2004; Martin and St  Johnston, 2003)). 
 
2.3 Epithelial cell polarity in vertebrates and Drosophila 
Sheets of epithelial cells line the cavities and surfaces throughout the body of 
multicellular organisms. They function as barriers between compartments and are 
essential for the transport of molecules between them. In order to function, epithelial 
cells have to be polarized into apical and basolateral membranes and form junctions 
with each other. A key feature of all epithelial cells is the polarized assembly of actin 
filaments at the cytosolic side of the apical and the basal cytoplasmic membrane. In 
both Drosophila and vertebrates, the apical identity of epithelia cells is maintained and 
regulated by two conserved polarity modules: the Crumbs module and the Par module. 
The Crumbs module is composed of Crumbs, PALS1 (Stardust in Drosophila) and Patj 
(PALS1 associated tight junction protein), the Par module is composed of Par3 
(Bazooka in Drosophila), Par-6 and atypical protein kinase C (aPKC). On the 
basolateral sides of the cells the Scribble polarity module composed of Scribble (Scrib), 
Dlg (Discs large) and Lgl (Lethal (2) giant larvae) defines basolateral identity. The 
polarity modules show mutually antagonistic interactions, restricting the activity of each 
module and regulate positioning of the adherens junctions (Humbert et al., 2008).  
While many basic mechanisms of cell polarity are conserved, the junctions along the 
lateral side of epithelial cells are organized differently in vertebrates and Drosophila 
(Knust and Bossinger, 2002).  
In vertebrates the apical domain contains a brush border of microvilli with a network of 
actin and Spectrin filaments beneath on the cytosolic side. The primary cilium protrudes 
from the apical surface and has a unique membrane and protein composition. Tight 
junctions mark the border of the apical and lateral domains; they include homophilic 
adhesion molecules like Occludin, JAMs (Junctional Adhesion Molecules) and 
Claudins that form a paracellular diffusion barrier. Adherens junctions are found basally 
of the tight junctions and are the main connection between neighboring cells. Nectins 
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and Cadherins localize to the adherens junctions and mediate these homophilic 
connections (Nelson et al., 2013). Only the basal side of the cell is connected to the 
extracellular matrix and has integrins and dystroglycan as receptors (Johnston and 
Ahringer, 2010). 
Epithelial cells of Drosophila lack primary cilia. The adherens junctions of most 
Drosophila epithelial cells are apical of the septate junctions and contain DE-Cadherin 
and Nectin (Baumann, 2001). Instead of tight junctions septate junctions function as the 
paracellular diffusion barrier in Drosophila and contain Sinuous (a claudin family 
member), Cor and Megatrachea (Wu et al., 2004). Unlike in vertebrates, the Spectrin 
cytoskeleton of Drosophila epithelia cells is polarized, with α2βH2-Spectrin at the apical 
and α2β2-Spectrin at the basolateral membrane (Thomas and Kiehart, 1994). The 
mammalian ortholog of βH–Spectrin shows no distinct apical distribution (Stabach and 
Morrow, 2000).  
 
2.4 Drosophila neuronal stem cells (neuroblasts) as a model for 
asymmetric cell division and stem cell induced tumors 
During stage 9 of embryogenesis, neural stem cells called neuroblasts (NBs) delaminate 
from the neuroectodermal epithelium into the interior of the embryo. NBs divide 
asymmetrically, giving rise to another NB (stem cell renewal) and a ganglion mother 
cell (GMC), that divides once more to form a pair of neurons or glia cells.  
The asymmetric division of a NB requires apical-basal polarity, which is partly 
inherited from the epithelium (Wodarz and Huttner, 2003). During metaphase the Par 
module, as well as the Insc/Pins/Gαi complex, is localized to the apical cortex, while 
cell fate determinants like Prospero, Brat and Numb and their adaptor proteins Miranda 
and Partner of Numb are localized to the basal cortex. The mitotic spindle is first 
oriented in parallel to the surface of the epithelium but rotates by 90° during metaphase. 
As the NB divides, the apically localized daughter cell inherits the apically localized 
proteins and retains stem cell fate. The smaller basal daughter cell inherits the proteins 
of the basal cortex and becomes a GMC (Wodarz, 2005). 
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The apical-basal polarity of the NB cortex is adjusted with the spindle orientation 
during metaphase and essential for asymmetric division (Lee et al., 2006). Defects in 
cell polarity of NBs can lead to symmetric divisions, resulting in formation of ectopic 
NB-like stem cells, which proliferate and finally lead to tumor formation (Wodarz and 
Näthke, 2007).  
 
2.5 The PAR proteins 
The PAR proteins were discovered as regulators of cytoplasmic partitioning in the early 
embryo of C. elegans. PAR stands for ”abnormal embryonic PARtitioning of 
cytoplasm”, describing  the phenotype of par mutants, which is a mislocalization of 
germ line-specific P granules (Kemphues et al., 1988). Following the nomenclature for 
genes and proteins in C. elegans, these six proteins required for early polarity and 
asymmetric cell divisions were named PAR-1 to PAR-6. During one cell stage PAR-3 
and PAR-6 become enriched in the anterior cortex, while PAR-1 and PAR-2 become 
enriched in the posterior cortex. PAR-4 and PAR-5 are symmetrically localized cortical 
and cytoplasmic (Goldstein and Macara, 2007). 
The biochemical roles of the PAR proteins differ remarkably. PAR-1 and PAR-4 are 
serine/threonine kinases, PAR-3 and PAR-6 contain PDZ domains (named after the 
three proteins Psd95, Discs large and ZO-1, that contain this domain) and PAR-2 is a 
protein with a “ring finger” zinc binding domain (Kemphues, 2000). With the exception 
of PAR-2, which seems to be a nematode-specific protein, homologs of the PAR protein 
have been identified in all bilateral animals investigated (examples in Table 2-1) and 
have been found to regulate cell polarization in multiple contexts in various animals 
(Goldstein and Macara, 2007).  
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Table 2-1: Homologs of PAR proteins 
Caenorhabditis elegans Drosophila melanogaster Homo sapiens 
PAR-1 Par-1 MARK1 
PAR-2 - - 
PAR-3 Bazooka PAR3 
PAR-4 LKB1 STK11/LKB1 
PAR-5 14-3-3ε and 14-3-3ζ 14-3-3 protein family 
PAR-6 Par-6 PAR6 
 
2.6 LKB1 (STK11, PAR-4) is a multifunctional protein kinase with 
tumor suppressor activity 
Germline mutations of human LKB1 (also known as STK11) are the main cause of 
Peutz-Jeghers-Syndrome (PJS) (Hemminki et al., 1998), a rare autosomal cancer 
disease. PJS is characterized by intestinal hamartomatous polyposis and mucocutaneous 
melanin pigmentation (Jeghers, 1949). Patients with PJS have a very high risk of 
developing cancer (Giardello et al., 2000). Somatic mutations of lkb1 are associated 
with a wide variety of mainly epithelial cancers (Sanchez-Cespedes, 2007), especially 
lung adenocarcinomas (Conde et al., 2007). Some cancer cell lines show severly 
reduced mRNA levels of LKB1, probably due to hypermethylation of the promoter 
region of lkb1. In HeLa S3 cells (a cervical cancer cell line) and in G361 cells (a 
melanoma cell line) reintroduction of functional LKB1 suppresses proliferation by 
growth arrest in G1 phase (Tiainen et al., 1999). On the other hand many malignant 
tumors appear to have elevated LKB1 expression levels (Rowan et al., 2000). 
LKB1 is a ubiquitously expressed serine/threonine kinase (also called STK11), which is 
known to phosphorylate the AMPK-family of 13 kinases and therefore termed a “master 
kinase” (Lizcano et al., 2004). In humans there are two LKB1 isoforms, resulting from 
alternative splicing. The long LKB1 form (50 kDa) is ubiquitously expressed in adult 
tissues, with higher expression in epithelia (Rowan et al., 2000). In the shorter form (48 
kDa) the C-terminus is replaced by a shorter and unique amino acid sequence (Towler et 
al., 2008). Both isoform are expressed in human tissues, but the shorter form is 
especially prevalent in testis, where it has been identified to be crucial for 
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spermiogeneis (Towler et al., 2008). The catalytic domain of LKB1 is poorly related to 
other protein kinases, the N-terminal and C-terminal non-catalytic regions are not 
related to any other proteins and posess no idenfiable domains (Boudeau et al., 2003b).  
Diverse effects of LKB1 have been observed on the cellular level, such as inducing cell 
cycle arrest (Tiainen et al., 1999), mediating apoptosis through p53 (Karuman et al., 
2001 and Cheng et al., 2009), AMPK activation in energy metabolism (Shackelford and 
Shaw, 2009) and cell migration (Zhang et al., 2008). The observation that activation of 
mammalian LKB1 can polarize cells  even in the absence of cell-cell contacts (Baas et 
al., 2004) has drawn attention to the role of LKB1 in cell polarity (2.6.6). While there 
are several downstream processes described, upstream regulation is poorly understood 
and might be mediated by localization rather than activation of kinase activity (Sebbagh 
et al., 2011).  
 
2.6.1 The heterotrimeric complex LKB1-STRAD-Mo25 is the active unit of 
LKB1 
LKB1 activity is highly increased by binding to the pseudo kinase STRAD (STe-20 
Related Adaptor) (Baas, 2003). This interaction is stabilized by Mo25 (mouse 
protein25) (Boudeau, 2003). Together they form the LKB1-STRAD-Mo25 
heterotrimeric complex, which is generally considered as the biologically active unit of 
LKB1. In the presence of STRADα and Mo25, LKB1 relocalizes from the nucleus to 
the cytoplasm as observed in several overexpression studies on mammalian cell cultures 
(Baas et al., 2003; Boudeau et al., 2003; Dorfman and Macara, 2008; Dension et al., 
2009). The structure of the LKB1-STRAD-Mo25 complex has been determined, 
showing that STRAD and Mo25 promote the active conformation of LKB1 (Zeqiraj et 
al., 2009).  
 
2.6.2 The LKB1-STRAD-Mo25 complex is probably conserved in lower 
model organisms 
Lower organisms also express STRAD and Mo25 homologs, which contain the critical 
residues for the interaction with LKB1, like the STRAD C-terminal WEF motif (Zeqiraj 
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et al., 2009). In C. elegans the STRAD homolog STRD-1 is required for the 
phosphorylation of AMPK by the LKB1 homolog PAR-4 under reduced insulin 
signaling conditions to regulate cell growth and proliferation, but the phosphorylation of 
key proteins like PAR-1 by PAR-4, which is needed for establishment of early 
embryonic polarity, is independent of STRD-1 (Narbonne et al., 2010). Mo25 has been 
shown to interact with LKB1 in Drosophila neuroblasts and both could be co-
immunoprecipitated reciprocally from embryonic lysates (Yamamoto et al., 2008). The 
Drosophila STRAD homolog Ste20-like kinase has not yet been investigated, but lacks 
key residues for kinase activity, indicating that it is also a pseudokinase (Anamika et al., 
2009). Although the LKB1-STRAD-Mo25 complex is not established for these 
organisms yet, these findings suggest that it is probably conserved. 
 
2.6.3 Posttranslational modification and regulation of LKB1 activity 
The observation that LKB1 can phosphorylate and activate almost all known members 
of the AMPK kinase family (Lizcano et al., 2004) suggests that it has to be tightly 
regulated to facilitate specific responses.  
Several phosphorylation sites have been found on mammalian LKB1. Four threonines 
(T) were identified as autophosphorylation sites, which are known to be positively 
correlated with activation of its catalytic activity (Baas et al., 2003). ATM mediates 
phosphorylation of LKB1 at T366 (Sapkota et al,, 2002b), which has no effect on the 
catalytic activity of LKB1, but seems to be required for inactivation of CRTC2, a 
coactivator of CREB, in B cell proliferation (Sherman et al., 2010). Phosphorylation of 
S428 by p90(RSK) and PKA (cAMP-dependent protein kinase) does not affect LKB1 
kinase activity but has been described to be essential for LKB1 to suppress cell growth 
(Sapkota et al., 2001). Other phosphorylation sites have been described, but the 
respective kinases and their function are not known. Their substitution with alanine, 
however,  had no observable effect on LKB1 kinase activity (Sapkota et al., 2002a). 
Until now little knowledge is established about the regulation of the kinase activity of 
LKB1. Remarkably, there is no LKB1 complex activating factor known (Sebbagh et al., 
2011), which lead to the hypothesis that the LKB1 complex could be constitutively 
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active and that specific responses are regulated by its intracellular localization (Fogarty 
and Hardie, 2009; Sebbagh et al., 2009). Two chaperone complexes have been 
suggested to control the cellular level of LKB1 protein: The chaperone heat shock 
protein 90 (Hsp90) and its co-chaperone Cdc37 inactivate LKB1, while Hsp/Hsc70 and 
CHIP trigger LKB1 degradation, which finally controls the cellular level of LKB1 
protein (Gaude et al., 2012). 
 
2.6.4 LKB1 in Drosophila 
The lkb1 gene (also known as dlkb1) of Drosophila was first identified in a genetic 
screen for mutants that disrupt the localization of Staufen in germline clones (Martin & 
St Johnston 2003). Due to its stronger homology to the human tumor-suppressor LKB1 
than to C. elegans PAR-4 it was named lkb1. In the same study, lkb1 is described to be 
important for the establishment of cell polarity in the follicle cell epithelium (Martin & 
St Johnston 2003). The oocyte phenotype resembled that of hypomorphic mutants in 
Drosophila par-1 and a strong genetic interaction between these genes has been 
observed. A par-1 hypomorphic mutation could be rescued by GFP-LKB1 
overexpression, but not by a kinase dead version of GFP-LKB1, while lkb1 mutant 
germline clones could not be rescued by PAR-1 overexpression. This and in vitro 
experiments indicated PAR-1 is not a substrate for LKB1. Instead, the amino-terminal 
half of LKB1 was identified to be phosphorylated by PAR-1, which led to the idea that 
LKB1 acts downstream of PAR-1 (Martin & St Johnston 2003). But Wang et al. could 
identify that LKB1 phosphorylates PAR-1 at the threonine residue at position 408 
(T408) in vitro and in vivo (Wang et al., 2007). Through biochemical experiments as 
well as genetic studies of Drosophila retinal phenotypes they have shown that LKB1 
acts upstream of PAR-1 and tau in a cytotoxic pathway in a model for 
neurodegenerative diseases (Wang et al., 2007).  
 LKB1 has been reported to phosphorylate AMPK (AMP-activated protein kinase) to 
control cell polarity and mitosis under energetic stress in the embryo (Lee et al., 2007) 
In the retina, LKB1 has been observed to act on an array of targets to regulate polarity 
remodeling probably independent of AMPK, possibly through PAR-1 and several 
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AMPK-like kinases (Amin et al., 2009). It has been reported that Drosophila LKB1 
negatively regulates organ size by inducing caspase-dependent apoptosis without 
affecting cell size or cell cycle progression (Lee et al., 2006). Silnoon, a 
monocarboxylate transporter, was identified as a modifier enhancing LKB1- dependent 
apoptosis, and is reported to be transported to the apical side of polarized cells 
depending on the kinase activity of LKB1 (Jang et al., 2008). In larval neuroblasts lkb1 
mutations are reported to lead to defects in apical polarity (Bazooka, Par-6 and aPKC 
localization are not properly localized), suppress asymmetric cell division and disrupt 
spindle formation resulting in polyploid cells in larval brains (Bonaccorsi et al., 2007). 
Overexpression of a GFP-tagged LKB1 fusion protein has been observed to reduce the 
size of embryos and localizes to the cortex of ectodermal embryonic epithelial cells and 
NBs. In NBs, the overexpression of LKB1 causes a broader distribution of Miranda 
along the cortex. This effect has been observed to be independent of the kinase activity 
of LKB1 (Yamamoto et al., 2008). A gain-of-function screen identified that 
overexpression of LKB1 reduced organ size and extended lifespan (Funakoshi et al., 
2011). 
 
2.6.5 AMPK as a downstream target of LKB1 
LKB1 has been shown to be the dominant regulator of AMPK (AMP-activated protein 
kinase) activation in several mammalian cell types by phosphorylating a critical 
phosphorylation site in its T-loop (T172) (Shaw et al., 2004). Low energy conditions 
increase the level of AMP and ADP, which interact with the CBS motifs of the AMPKγ 
subunit of AMPK (Hardie, 2011). This causes conformational changes that activate the 
AMPKα subunit and promote phosphorylation of the phosphorylation site T172 by 
inhibiting its dephosphorylation (Sanders et al., 2007). The activation of the AMPKα1 
and AMPKα2 catalytic subunits functions to restore energy levels by phosphorylating 
an immense number of proteins, which are involved in multiple processes like 
metabolism, cell growth and proliferation (Carling et al., 2011). The net result of 
AMPK activation is a shift of the balance from anabolic to catabolic function and 
thereby restoring the cellular ATP levels of the cell. 
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The tumor suppressor activity of LKB1 is thought to be at least partly mediated by its 
activation of AMPK, which in turn inhibits mTOR (mammalian target of rapamycin), 
which is a known regulator of diverse cellular processes including cell growth and 
proliferation (Shackelford and Shaw., 2009). In ciliated MDCK cells, LKB1 has been 
found to colocalize with AMPK at the basal body, where it regulates the 
phosphorylation of AMPK in response to urine flow, which regulates cell size through 
mTOR (Boehlke et al., 2010).  
In spite of its role as a tumor suppressor, LKB1 protects cells from apoptosis in 
response to elevated AMPK levels (Shaw et al., 2004). The LKB1-AMPK pathway can 
have a positive role in tumorigenesis by acting to maintain metabolic homeostasis and 
attenuate oxidative stress and thus enabling the survival of tumor cells by maintaining 
NADPH levels (Jeon et al,. 2012). This might also explain why many malignant tumors 
display elevated levels of LKB1 (Rowan et al., 2000). 
ampk-null mutant Drosophila embryos are reported to be lethal with abnormal cell 
polarity and mitosis, similar to those in lkb1-null mutants and a phosphomimetic mutant 
of myosin II regulatory light chain (MRLC) rescued the phenotype of ampk-null 
mutants to some extent (Lee et al., 2007). This indicates that the actin-myosin 
cytoskeleton might be regulated by AMPK under energetic stress conditions. Although 
Lee et al. could show that AMPK phosphorylates MRCL in Drosophila and in the 
human epithelial cell line LS174T, in mammalian pancreatic cells the inhibition of 
LKB1 did not affect the phosphorylation status of MRLC (Hezel et al., 2008) and 
inhibition of AMPK in vascular smooth muscle cells even increased MRLC 
phosphorylation (Horman et al., 2008). This indicates that MRLC may not be directly 
phosphorylated by AMPK but that it may mediate the polarity signal from AMPK to the 
actin cytoskeleton (Mirouse and Billaud 2011). Many aspects regarding an involvement 
of AMPK in cell polarity like its direct downstream targets associated with this function 
remain unclear. The cytoplasmic linker protein of 170 Da (CLIP-170) has been 
proposed to be a target of AMPK involved in cell polarity by affecting the stability of 
microtubules (Nakano et al., 2010). 
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2.6.6 LKB1 in the regulation of cell polarity 
Activation of LKB1 by overexpression of its adaptor protein STRAD was reported to 
induce polarization even in the absence of cell-cell contacts in human intestinal 
epithelial cells, as seen by the formation of an actin-rich brush border on one side of the 
cell, indicating an apical-like surface (Baas et al., 2004). This suggests that LKB1 is a 
major regulator of cell polarity. Mst4 and the actin filament binding protein ezrin were 
later identified as downstream targets of LKB1 in the induction of brush border 
formation, but had no effect on other polarity events downstream of LKB1, like the 
formation of lateral junctions (Klooster et al., 2009). The role of LKB1 in actin filament 
assembly has been further investigated in HeLa cells, which lack endogenous LKB1. In 
this process LKB1 expression leads to an activation of Rho, mediated by the guanine 
nucleotide exchange factor Dbl, although the exact mechanism remains unknown. 
Interestingly, the kinase activity of LKB1 is not required for the induction of stress 
fibers, but the kinase domain is (Xu et al., 2010). It has also been reported that LKB1 
regulates the expression of E-Cadherin and thereby intercellular junction stability 
through Salt-inducible kinase 1 (Eneling et al., 2012). On the other hand LKB1/STRAD 
localization has been reported to be localized to the adherens junctions of polarized 
epithelial cells (MDCK cells) under control of E-Cadherin (Sebbagh et al., 2009).                               
 
2.6.7 Localization of LKB1 
A nuclear localization signal (NLS) has been identified in the N-terminus of 
mammalian LKB1 (Nezu et al., 1999; Smith et al., 1999; Tiainen et al., 2002). 
Localization of LKB1 has mostly been studied in mammalian overexpression systems in 
cell culture (Table 2-2). In most of these studies, LKB1 has been observed 
predominantly in the nucleus and to a lower degree in the cytosol (Nezu et al., 1999; 
Smith et al., 1999; Tiainen et al., 1999; Baas et al., 2003; Boudeau et al., 2003; Denison 
et al., 2009; Dorfman and Macara et al., 2008; Xie et al., 2008). STRADα has been 
reported to regulate export of LKB1 through inhibition of the nuclear import of LKB1 
and by serving as an adaptor between LKB1 and exportins CRM1 and exportin 7 
(Dorfman and Macara, 2008). Some studies have also found localization of LKB1 to the 
cytocortex (Collins et al., 2000; Sapkota et al, 2001; Xu et al., 2010).  
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The localization of LKB1 in cells expressing endogenous levels of LKB1 has not been 
investigated much, probably due to low expression levels and lack of suitable antibodies 
(Sebbagh et al., 2009). Surprisingly, in MDCK cells, endogenous LKB1 is reported to 
localize mainly to the cytosol and membrane and not to the nucleus (Sebbagh et al., 
2009). A fractionation study of HEK293 cells, which express moderate amounts of 
endogenous LKB1, was only able to detect LKB1 in the cytosolic and membrane 
fractions, but not in the nuclear fraction (Denison et al., 2009). Fractionation of 
polarized Caco-2 cells revealed an absence of LKB1 in the nuclear fraction, but showed 
abundance in the cytosolic and membrane fractions (Sebbagh et al., 2009). It can be 
assumed, that the examined cell lines express enough STRAD to export the endogenous 
amounts of LKB1 from the nucleus. 
Table 2-2: Localization of LKB1 in mammalian cell culture lines 
Cell line 
(type) 
LKB1 localization Method 
Expresses 
endogenous 
LKB1 
Reference 
A549 
(human alveolar 
basal epithelial 
cells) 
nuclear 
immunocytochemical 
detection of tagged fusion 
protein 
no Xie et al., 2008 
CCL13 
(human 
hepatocytes) 
nuclear +cytosolic 
(activation by 
STRAD+Mo25  
cytosolic) 
immunocytochemical 
detection of tagged fusion 
protein 
no 
Dension et al.,, 
2009 
COS-7 
nuclear  
cytosolic 
immunocytochemical 
detection of tagged fusion 
protein 
 Smith et al., 1999 
CV-1 
(kidney fibroblast 
cells from 
normal african 
green monkey) 
plasma membrane and 
internal membranes 
(farnesylation deficient 
mutant does not 
localize to membranes)  
fluorescence tagged 
protein 
yes 
Collins et al., 
2000 
G361 
(human 
melanoma) 
nuclear 
cytosolic 
overexpression, 
immunocytochemical anti-
LKB1 antibody 
impaired 
endogenous 
level 
Tiainen et al., 
1999 
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Cell line 
(type) 
LKB1 localization Method 
Expresses 
endogenous 
LKB1 
Reference 
HeLa 
(cervical 
carcinoma) 
 
nuclear 
cytosolic 
(coexpression of 
STRAD  cytosolic) 
fluorescence tagged 
protein 
 
no 
Boudeau et al., 
2003; 
Dorfman and 
Macara, 2008 
HeLa-S3 
(cervical 
carcinoma) 
nucleus, fraction at cell 
membrane 
immunocytochemical 
detection of tagged fusion 
protein 
no Xu et al., 2010 
HUVEC 
(Human 
Umbilical Vein 
Endothelial Cells) 
nuclear 
(treatment with 
metformin  
cytosolic) 
immunocytochemical 
detection of tagged fusion 
protein 
yes Xie et al., 2008 
LS174T 
(human intestinal 
epithelial cancer) 
 
predominantly nuclear 
(coexpression of 
STRAD  cytosolic) 
 
immunocytochemical 
detection of tagged fusion 
protein 
Probably not 
(author 
statement) 
Baas et al., 2003 
Rat-2 
(fibroblast-like)  
mainly cytosolic, 
small but significant 
amount at membrane 
fractionation 
 
yes 
Sapkota et al., 
2000 
 
2.6.8 The C-terminus of LKB1 is involved in membrane targeting of LKB1 
 
Numerous mutations that affect only the C-terminus have been identified in tumors, 
making it an interesting area of investigation (Boudeau et al., 2003b). The C-terminal 
CAAX-sequence, which is only present in the long isoform of mammalian LKB1 and 
conserved in most model organisms including Drosophila (Figure 2-1), is a 
farnesylation motif (Collins et al., 2000; Sapkota et al., 2001; Martin and St Johnston, 
2003). In CV-1 cells and Drosophila oocytes a farnesylation-deficient mutant of LKB1  
strongly impairs the cortical localization of LKB1 (Collins et al., 2000; Martin and St 
Johnston, 2003). The overexpression of a farnesylation-deficient LKB1 mutant in 
mammalian cell culture, however, had no effect on the ability to suppress cell growth 
(Sapkota et al., 2001). With a farnesylation-specific antibody the majority of LKB1 was 
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identified to be farnesylated in wild-type mouse tissues and cultured cells (Houde et al., 
2014). A farnesylation deficient version of LKB1 (LKB1
C433S
) was investigated using 
mouse knockin analysis (Houde et al., 2014).  
Another motif at the C-terminus that is conserved in model organisms including 
Drosophila and C. elegans is the PKA/p90RSK phosphorylation motif “RKLS” (Figure 
2-1). In human endothelial cells it has been reported, that PKC-ζ phosphorylates LKB1 
at S428 and that this would lead to a nuclear export of LKB1 and hence AMPK 
activation (Xie et al., 2008). Others describe that this phosphorylation site is essential 
for mammalian LKB1 to suppress cell growth (Sapkota et al., 2001), but is not required 
for regulation of AMPK or cell cycle arrest (Fogarty and Hardie, 2009). In agreement 
with the latter mentioned findings, AMPK is activated normally in knockin mice 
carrying the phosphodeficient mutant LKB1
S431A
 (Houde et al., 2014). Co-expression 
and mobility shift assays of Drosophila LKB1 and PKA in S2 cells revealed a 
conservation of this phosphorylation site (Martin and St Johnston, 2003). Moreover, a 
GFP-LKB1 with a phosphodeficient version of this site, when expressed in low 
amounts, does not rescue localization of Staufen to the posterior oocyte of Drosphila, 
while a phosphomimetic version rescues even more efficiently than the wild type 
control, indicating a positive regulation of LKB1 by phosphorylation of this site (Martin 
and St Johnston, 2003).   
STK11[Homo sapiens]          1…409-R------APNPARKACSASSKIRRLSACKQQ------ 433 
LKB1[Mus musculus]          1…411-RPG----TANPARKVCS-SNKIRRLSACKQQ------ 436 
STK11[Danio rerio]                  1…415-SS-----SSNPSRKGLSAASKIRKLSTCKQQ------ 440 
XEEK1[Xenopus laevis]           1…411-SS---------QRKASTTGSKVRKLSACKQQ------ 432 
LKB1[Drosophila melanogaster]       1…537-PVKKKGSALKRRAKKLTSCISVRKLSHCRTS------ 567 
PAR-4[Caenorhabditis elegans]       1…581-GVASASDPPPTAAPGAPPRRRKRNFFSCIFRSRTDSA 617 
 
Figure 2-1: Alignment of the C-termini of LKB1 homologs. Blue color indicates the 
PKA phosphorylation motif and green color the farnesylation motif conserved between 
human LKB1 and homologs in model organisms. 
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2.6.9 Potential LKB1 interaction partners 
Apart from an activation of of the AMPK family of kinases (Licano et al., 2004), 
several potential LKB1 effectors have been identified by mass spectrometry and yeast 
two hybrid assays (Sebbagh et al., 2011). Interactions with the chaperone complexes 
Hsp90/Cdc37 and Hsp/Hsc79-CHIP have been reported to regulate activity and stability 
of LKB1 (Gaude et al., 2012). LKB1 has also been reported to interact with LIP1 
(LKB1 interacting protein 1), but the functional consequences of this interaction remain 
unknown (Smith et al., 2001). Similar to this, the interaction of LKB1 with PTEN was 
observed but no distinct functional consequences were found (Mehenni et al., 2005). 
Furthermore, an interaction of LKB1 with the transcription factors Estrogen receptor-α 
and Brahma related gene-1 has been described, but phosphorylation of these partners by 
LKB1 could not be observed, indicating a potential indirect effect of LKB1 (Marignani 
et al., 2001; Nath-Sain and Marignani, 2009). 
In order to find new potential interaction partners of LKB1, they were co-
immunoprecipitated by expressing GFP-LKB1 in Drosophila embryos and identified 
via mass spectrometry (Krahn, so far unpublished). The co-immunoprecipitation of the 
LKB1 substrate and the homologs of the components of the LKB1 complex (Stlk and 
Mo25), indicate that this approach is promising for the identification of interaction 
partners. Among the potential interaction partners are α-Spectrin and β-Spectrin, which 
are components of the membrane skeleton. In this work the potential interaction of these 
proteins with LKB1 were analyzed. 
 Table 2-3: Proteins identified to bind to GFP-LKB1  
Protein 
# of 
peptides 
Cellular function 
-Spectrin 5 Cytoskeleton linker protein 
-Spectrin 2 Cytoskeleton linker protein 
AMP-activated kinase 7 Regulation of cellular energy homeostasis 
Ste20-like kinase (Stlk) 24 Co-factor for LKB1 (STRADa homolog) 
Mo25 26 Co-factor for LKB1 
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2.7 The membrane skeleton 
Actin has critical roles in establishing and maintaining cell morphology, cell motility, 
cell division and intracellular transport (Pollard and Cooper, 2009). Most actin filaments 
in animal cells are nucleated at the plasma membrane, where they form a layer at the 
cytoplasmic side called the cell cortex or membrane skeleton, which is important for the 
shape and movement of the cell surface.  
 
2.7.1 Spectrin 
Spectrin has been studied mostly in human erythrocytes, were it forms a protein 
network by binding to actin and peripheral membrane proteins (Bennett, 1985; Byres 
and Brandon, 1985), which builds stiff structures that are important for the flexibility of 
this cell type. But it is found in all metazoan species and in almost all cells examined 
(Baines, 2009). In erythrocytes it is forming the Spectrin-based membrane cytoskeleton 
by crosslinking transmembrane proteins, signaling proteins, membrane lipids and the 
actin cytoskeleton, while the cortical composition of other cell types appears to be more 
complex (reviewed in Bennett and Baines, 2001). In the Drosophila neuromuscular 
junction an erythrocyte-like polygonal lattice structure has been reported (Pielage et al., 
2006), which has also been proposed for other cell types (Baines, 2010). 
Three types of Spectrins exist in invertebrates: α-Spectrin, β-Spectrin and βH-Spectrin. 
α-Spectrin is forming heterotetrameric complexes with β-Spectrin and βH-Spectrin (α2β2 
and α2βH2) (Dubreuil et al., 1990). The Spectrin cytoskeleton of Drosophila epithelial 
cells is polarized, with α2βH2 found in the apical cortex of polarized cells and α2β2 in the 
basolateral cortex (Thomas and Kiehart, 1994). In a Spectrin dimer, α- and β-chains lie 
side-by-side and antiparallel. The Spectrin proteins are linking actin fibers and other 
proteins by numerous interaction motifs. Both α-Spectrin and β-Spectrin are mostly 
made of triple-helical repeats. α-Spectrin contains a middle SH3 domain and a C-
terminal EF-hand binding motif in addition to multiple Spectrin repeats. SH3 domains 
are protein interaction domains that bind to proline-rich ligands, that play several 
different roles in the cell including the regulation of enzymes, changing the subcellular 
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localization of signaling pathway components, and mediating the formation of 
multiprotein complex formations (Macheler-Bauer et al., 2011).The β-Spectrin N-
terminal region contains a pair of CH domains that binds actin, adducin and 
Phosphatidylinositol-4,5-bisphosphate (PIP2). Triple helical repeats 14–15 contain an 
ankyrin binding site. Other triple helices in both chains bind a variety of different 
ligands, including the region between repeats 9 and 11 (including the SH3 domain) 
which can bind both proteins and phospholipids (Baines, 2009).  
In human epithelial cells loss of β-Spectrin or ankyrin has been shown to lead to loss of 
the lateral membrane (Kizhatil, 2007). Apical α2βH2 is needed in the Drosophila follicle 
cell epithelium for epithelial morphogenesis but not for apicobasal polarity (Zarnescu 
and Thomas, 1999). Genetic experiments in C. elegans suggest a requirement for 
Spectrins in muscle and nerves (Hammarlund et al., 2000; Moorthy et al., 2000). 
Analysis in Drosophila Spectrin mutants indicate the need of Spectrin and ankyrin in 
the consolidation and maintenance of synaptic structures (Pielage et al., 2005, 2006 and 
2008) and distinct roles of α-Spectrin and β-Spectrin in axonal pathfinding (Hülsmeier 
et al., 2007). 
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3 Material and Methods 
3.1 Material 
Chemicals (Table 3-1) and kits (Table 3-3) were bought from following companies: 
Agilent Technologies (Böblingen, Germany), BioVision (San Francisco, USA), 
Chromotek (Planegg, Germany), Invitrogen (Groningen, Netherlands), Machery-Nagel 
(Düren, Germany), Merck Chemicals Ltd. (Nottingham, UK), PAN biotech (Aidenbach, 
Germany), Promega (Mannheim, Germany), Roche Diagnostics Deutschland GmbH 
and Roche Applied Science (Mannheim, Germany), Roth (Karlsruhe, Germany), 
Sigma-Aldrich (Steinheim, Germany) and Thermo Fisher Scientific. Chemicals were 
generally of analytical grade. 
Instruments and other material were purchased from Carl Zeiss (Jena, Germany), 
Echelon Biosciences (Salt Lake City, USA), Eppendorf (Hamburg, Germany), Intas 
(Göttingen, Germany), Machery-Nagel (Düren, Germany) and Thermo Fisher 
Scientific.  
 
3.1.1 Reagents 
 
Table 3-1: Reagents 
Reagent Utilization Note Company 
Albumin fraction 
V 
Blocking Solutions  Roth 
Amlyose Resin 
Protein Purification of 
MBP-tagged proteins 
 
New England 
BioLabs 
Aprotinin Protease inhibiton 
used 
concentration: 2 
µg/ml 
Roth 
Bradford Rothi
®
 
Quant 
 
Coomassie Brilliant 
Blue-G250 
Protein 
concentration 
measurement 
Roth 
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Reagent Utilization Note Company 
FuGENE
®
HD 
Transfection 
Reagent 
Transfection of Cells 
Blend of Lipids in 
80% Ethanol 
Promega 
GFP-Trap Co-IP 
GFP-Trap
®
 
coupled to 
agarose beads 
particle size ~80 
µm; stored in 
20% EtOH 
Chromotek 
Leptomycin B 
Inhibition of CRM1 
(exportin 1, embargoed) 
Used 1:100 Sigma-Aldrich 
Leupetin Protease inhibiton 
used 
concentration : 2 
µg/ml 
Roth 
Pepstatin A Protease inhibiton 
used 
concentration : 2 
µg/ml 
Roth 
PfuS Polymerase PCR Homemade - 
Phosphatase 
Inhibitor Cocktail 
Set, IV 
Phosphatase Inhibitors 
Phosphatase 
Inhibitors 
Merck 
PMSF Protease inhibiton  Roth 
Protein A 
sepharose 
Co-IP 
Supplied as 50% 
slurry in 20% 
Ethanol/H2O 
BioVision 
Protino 
Glutathione 
Agarose 4B 
Protein Purification of 
GST-tagged proteins 
 Macherey-Nagel 
T4 DNA Ligase Ligation  
Thermo Fisher 
Scientific 
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3.1.2 Solutions 
Solutions were prepared with distilled water and sterilized by autoclaving or sterile 
filtration. Instruments and other material were purchased from Carl Zeiss (Jena, 
Germany), Echelon Biosciences (Salt Lake City, USA), Eppendorf (Hamburg, 
Germany), Intas (Göttingen, Germany), Machery-Nagel (Düren, Germany) and Thermo 
Fisher Scientific. 
  
 
Table 3-2: Solutions 
Name Composition Usage 
Apple juice agar 
plates (2%) 
1980 ml H2O  
60 g Agar  
1020 ml Apple juice 
51 g Sugar 
10% Nipagin in ethanol 
Egg collection, feeding 
Blocking Buffer (for 
Western Blots) 
500 ml TBST; 
3% skim milk powder; 
1% BSA 
Western Blot 
Blocking Buffer 
TBS (50 mM Tris-HCl, 
pH 7.4, 150 mM NaCl), 
3% BSA 
Lipid overlay assay 
Buffer A 
100 mM Tris-HCl, pH 
7.5 
100 mM EDTA 
100 mM NaCl 
1% SDS 
Isolation of genomic 
DNA from adult flies 
Buffer G (10x) 
10 mM Tris-HCl (pH 
7.5 at 37°C); 10 mM 
MgCl2; 50 mM NaCl; 
0.1 mg/ml BSA 
Buffer System for 
restriction enzymes; 
Thermo Fisher 
Scientific 
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Name Composition Usage 
Buffer O (10x) 
50 mM Tris-HCl (pH 
7.5 at 37°C); 10 mM 
MgCl2;100 mM NaCl; 
0.1 mg/ml BSA 
Buffer System for 
restriction enzymes; 
Thermo Fisher 
Scientific 
Buffer R (10x) 
10 mM Tris-HCl (pH 
8.5 at 37°C); 10 mM 
MgCl2; 100 mM KCl; 
0.1 mg/ml BSA 
Buffer System for 
restriction enzymes; 
Thermo Fisher 
Scientific 
Buffer Tango (10x) 
33 mM Tris-acetate (pH 
7.9 at 37°C); 10 mM 
Mg-acetate; 66 mM K-
acetate; 0.1 mg/ml BSA 
Buffer System for 
restriction enzymes; 
Thermo Fisher 
Scientific 
DAPI 5 µg/ml DNA staining 
Embryo-Glue adhesive tape; heptane 
Mounting of embryos 
for injection 
 
Fixation Solution 
PBS (1x); 4% 
Formaldehyde 
Fixation 
Freezing Medium 
45% conditioned 
medium; 45% fresh 
medium; 
10% DMSO 
Freezing Cells 
LB Medium 
10 g Bacto-Tryptone; 
5 g Bacto-Yeast Extract; 
10 g NaCl 
E.coli liquid culture 
medium 
LBAmp Medium 
10 g Bacto-Tryptone; 
5 g Bacto-Yeast Extract; 
10 g sodium chloride; 
500 µg/ml Ampicillin 
Selective liquid culture 
medium for E.coli 
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Name Composition Usage 
LB0 Plates 10% tryptone; 5% 
Yeast extract; 
5% sodium chloride; 
15% Agar Agar; pH 7.0 
 
LBamp Plates 
LB0 Plates + 100 mg/l 
ampicillin 
selective ampicillin 
plates 
LBkana Plates 
LB0 Plates + 50 mg/l 
kanamycin 
selective kanamycin 
plates 
LBchl Plates 
LB0 Plates + 30 mg/l 
chloramphenicol 
selective 
chloramphenicol plates 
LiCl/KAc Solution 
4,29 M lithium chloride 
1,43 M potassium 
acetate 
Isolation of genomic 
DNA from adult flies 
Loading Buffer (6x) 
2.5% Ficoll 400; 11 mM 
EDTA; 3.3 mM Tris-
HCl; 0.017% SDS; 
0.015% 
Bromophenolblue 
(pH 8.0) 
Agarose Electrophoresis 
Lysis Buffer 
TNT Buffer; 
Leupeptin; Pepstatin; 
Pefabloc/PMSF; 
Aprotinin (1:500 each) 
 
Co 
Immunoprecipitation 
Methylene Blue 
solution 
Methylene blue powder 
ddH2O 
Agarose gel staining 
Mowiol 
0.4 g/ml Mowiol; 
1 g/ml Glycerol; 
2% 0.2 M Tris-HCl 
Embedding Medium 
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Name Composition Usage 
NP-40-lysis-buffer 
50 mM Tris, pH7.5 
140 mM NaCl 
1% NP40/Igepal 
1 mM CaCl2 
1 mM MgCl2 
Lysis of embryos 
P1-Buffer 
50 mM Tris-HCl (pH 
8.0); 10 mM EDTA; 
100 µg/ml RNase A 
Storage 4°C 
Mini-Preparation 
P2-Buffer 
200 mM NaOH; 1% 
SDS 
Mini-Preparation 
P3-Buffer 
3.0 M potassium 
acetate, pH 5.5 
Mini-Preparation 
PBS (10x) 
58.44 g/mol NaCl; 
74,55 g/mol KCl; 
141.96 g/mol Na2HPO4; 
136 g/mol KH2PO4 
Washing Buffer 
PBT 
PBS (1x); 0.1% 
Tween20 
Immunohistology  
Schneider’s 
Drosophila Medium 
With L-Glutamine; 
0.40 g/l NaHCO3 
Transfection Medium, 
PAN biotech 
Schneider’s 
Drosophila Medium 
(Complete) 
With L-Glutamine; 
0.40 g/l NaHCO3; 
5% 
Penicillin/Streptomycin; 
10% FCS 
Liquid culture medium 
for Drosophila 
Schneider Cells, PAN 
biotech 
2X SDS Loading 
Buffer (Laemmli 
Buffer) 
126 mM Tris (pH 6,8); 
4% SDS; 0.2% 
bromophenol blue; 20% 
glycerol; 200 mM DTT 
SDS-PAGE 
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Name Composition Usage 
6X SDS Loading 
Buffer  
375 mM Tris (pH 6,8) 
9% SDS 
0.03% bromophenol 
blue 50% glycerol 
600 mM DTT 
SDS-PAGE 
SDS Running Buffer 
(10x) 
1.92 M Glycine 
250 mM Tris 
1% SDS 
SDS-PAGE 
TE 
10 mM Tris-HCl, pH 
8.0 
1 mM EDTA 
 
TAE (1x) 
40 mM Tris-Base 1 mM 
EDTA 0.1 % acetic acid 
Agarose Electrophoresis 
TBS (1x) 
50 mM Tris-HCl, pH 
7.4 150 mM NaCl 
Western Blot 
TBST 0,1% 
1 mM Tris-HCl; pH 8.0; 
150 mM NaCl; 
0.1% Tween 20 
Western Blot 
TNT Lysis Buffer 
150 mM NaCl; 
50 mM Tris pH 7.5; 
1% Triton X-100 
Co 
Immunoprecipitation 
Transfer Buffer 
(10x) 
250 mM TRIS-base 
1.9 mM Glycine 
Western Blot 
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3.1.3 Commercial kits 
 
Table 3-3: Commercial Kits 
Kit Utilization Company 
BM Chemiluminescence 
Western Blotting Substrate 
(POD)  
Western Blot Analysis Roche 
In situ Cell Death 
Detection Kit, TMR red 
TUNEL-assay for 
apoptosis detection  
Roche 
pEntr/D-Topo Cloning Kit Gateway Cloning Invitrogen 
Nucleo Bond
®
 PC 100 Midi-Preparation Macherey-Nagel 
Nucleo Spin
®
Gel and PCR 
Clean-Up 
PCR Purification Macherey-Nagel 
QuikChange  Site-directed mutagenesis Agilent Technologies 
Super Signal West Pico 
Chemiluminescence 
Substrate 
Western Blot Analysis Thermo Scientific 
   
 
3.1.4 Instruments and other material 
 
Table 3-4: Instruments and other material 
Name  Utilization Company 
Mikro-Dialysierkapsel 
QuixSep 
(max. Volume 1 mL) 
Dialysis Roth 
Slide-A-Lyzer Dialysis 
Cassettes 
Dialysis Thermo Scientific 
PIP Strips (P-6001) Lipid binding assay Echelon Biosciences 
Digital-Microscope VHX- Imaging of Drosophila Keyence 
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Name  Utilization Company 
500FC eyes 
NanoDrop 1000 
Spectrophotometer 
Measuring DNA 
concentration 
Thermo Scientific 
LSM 510 Meta Microscopy Zeiss 
LSM 710 Meta Microscopy Zeiss 
UV Transilluminator  Intas 
Femptotips
®
II 
Injection for germline 
transformation 
Eppendorf 
   
 
3.1.5 Antibodies 
 
Table 3-5: Primary antibodies 
Target Species Utilization Designation Origin/References 
aPKC (aPKCξ) Rabbit IF (1:500) sc-216 Santa Cruz 
Actin Rabbit IF (1:100) A2066 Sigma 
Phospho-AMPKα 
(Thr172) 
Rabbit 
WB(1:200) 
 
40H9 
Cell Signaling 
Technology 
α-Spectrin Mouse 
IF (1:20) 
WB (1:10) 
3A9 
Developmental 
Studies 
Hybridoma Bank 
(DSHB) 
Baz Nterm Rabbit IF (1:1000) DE99646-2 
Wodarz et al., 
1999 
β-Spectrin Rabbit IF (1:1000)  Christian Klämbt 
c-Myc Mouse 
IF (1:100) 
IF (1:50) 
9E 10 DSHB 
Crb Mouse IF (1:10)  Tepass 
DE-Cadherin Rat IF (1:10) DCAD 2  DSHB 
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Target Species Utilization Designation Origin/References 
Dlg Mouse IF (1:25) 4F3 (DSHB 
elav Mouse IF (1:20) 
9F8A9 
 
 DSHB 
GFP Rabbit IF (1:500) A11120 
Molecular probes 
(Invitrogen) 
HA Rat 
IF (1:1000) 
(1:100) 
  DSHB 
MBP Rat 
WB (lipid 
overlay 
experiments) 
1:5000 
1.1 MBP 
7G4 
 
Sigma Aldrich 
MBP Mouse WB (1:500) sc73416 
Santa Cruz  
 
LKB1 Guinea Pig 
IF/WB/Co-IP 
(1:500) 
SAC 288 
SAC 289 
Homemade 
LKB1 phospho Thr-
312 
Rabbit IF (1:500)  Homemade 
LKB1 phospho Thr-
460 
Rabbit IF (1:500)  Homemade 
Lgl Guinea Pig IF (1:500)   
Mir Rat IF (1:1000)  Homemade 
PATJ Guinea Pig IF (1:500)  Homemade 
α-tubulin Mouse WB (1:1000) 12G10 DSHB 
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Table 3-6 Secondary antibodies 
Antibody Species 
Utilization 
(Dilution) 
Origin/References 
Alexa Fluor 488-anti Guinea 
Pig 
Goat IF (1:200) Life Technologies 
Alexa Fluor 488-anti Rat Goat IF (1:200) Life Technologies 
Alexa Fluor 488-anti Rabbit Goat IF (1:200) Life Technologies 
Alexa Fluor 488-anti Mouse Goat IF (1:200) Life Technologies 
Alexa Fluor 568-anti Guinea 
Pig 
Goat IF (1:200) Life Technologies 
Alex Fluor a 568-anti Rabbit Donkey IF (1:200) Life Technologies 
Alexa Fluor 568-anti Rat Goat IF (1:200) Life Technologies 
Alexa Fluor 568-anti Mouse Donkey IF (1:200) Life Technologies 
Alexa Fluor 647-anti Guinea 
Pig 
Goat IF (1:200) Life Technologies 
Alexa Fluor 647-anti Rabbit Goat IF (1:200) Life Technologies 
Alexa Fluor 647-anti Rat Goat IF (1:200) Life Technologies 
Alexa Fluor 647-anti Mouse Goat IF (1:200) Life Technologies 
HRP-anti Guinea Pig Goat WB (1:10000) Roche 
HRP-anti Rabbit Goat WB (1:10000) Roche 
HRP-anti Rat Goat WB (1:10000) Roche 
HRP-anti Mouse Goat WB (1:10000) Roche 
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3.1.6 Oligonucleotides 
 
Oligonucleotides were designed with DNADynamyo (BlueTractorSoftware, UK) and 
synthesized by Biotez (Berlin, Germany) or Metabion (Martinsried, Germany). 
Plasmids were obtained from Amersham Pharmacia Biotech (now GE Healthcare Life 
Sciences), Invitrogen, Murphy lab (Carnegie Institution for Science, Department of 
Embryology, Baltimore, USA) and New England Biolabs (Frankfurt am Main, 
Germany). 
 
Table 3-7: Oligonucleotides 
Name Sequence 5’ → 3’ Description 
GST for CAGCAAGTATATAGCATGGC 
Sequencing of 
destination 
vectors 
LKB1-F 
CACC ATGCAATGTTCTAGCTCTCGG 
 
 
LKB1-N-R 
CTACGAAGTTCGGCAGTGG 
 
 
LKB1-C-R CGAAGTTCGGCAGTGGCT  
LKB1-EGFP-C1-F 
AAAAGATCTATGCAATGTTCTAGCTCTCGG 
 
 
LKB1-EGFP-C1-R 
AAAGAATTCG CTACGAAGTTCGGCAGTGG 
 
 
LKB1-302-R 
 
TGGCTTGATATCCTTGTGGA 
 
 
LKB1Exon5-seq-F 
GAACACGACGTAAATC 
 
Sequence 
primer 
LKB1 C564A-F 
 
GTG CGC AAG CTT AGC CAC GCC CGA ACT 
TCG TAG 
 
Mutagenesis 
of farnesyl 
acceptor 
cysteine 
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Name Sequence 5’ → 3’ Description 
LKB1DeltaNLS-F 
 
ATCATCTATCAGCAGGCCGCGGCGAGCATTAA
GATGGTG 
 
Mutagenesis 
of NLS??? 
LKB1Delta1-162-F 
 
GCCCCCTTCACCATGATCTATCAGCAGAAA 
 
N-teminal 
truncation 
LKB1Delta1-162-
R 
 
TTTCTGCTGATAGATCATGGTGAAGGGGGC 
 
N-teminal 
truncation 
LKB1 K201M-F 
 
AACCTGTGCCGGCTGGCCGTCATGATCCTGAC
TAAG 
 
Mutagenesis 
LKB1genomic-F 
 
CACC CACTAGCGTAATTTGACGG 
 
2830before 
Start 
 
LKB1genomic-R 
 
CTC GAG CAGCAGTACGGTCATCTC 
 
+ XhoI 
3kbp 
 
LKB1genomic2nd
Half-F 
 
CACC CATCTACATCATCCCACGG 
 
 
LKB1genomic2nd
Half-R 
 
CTC GAG GACATTTCCAGATTGCCCT 
 
+ XhoI 
2800bp 
 
LKB1genomic+Xb
aI-F 
 
GGCTCCGCGGAGGTTT TCT AGA 
CAATGTTCTAGCTCTC 
 
deletes Start 
codon 
 
LKB1GFP-F 
 
AAA TCT AGA ATGGTGAGCAAGGGC 
 
??? 
LKB1genomic+Xb
aI-F2 
GGGGCTCCGCGGAGGTTTTCTAGATGTTCTAG
CTCTCGGCCA 
Deletes 2aa 
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Name Sequence 5’ → 3’ Description 
  
LKB1-552-C-F 
 
CACCATGCTGACGTCCTGCATCTCCGTGCGCA
AGCTGAGCCACTGCCGAACTTCGTAG 
 
 
LKB1-552-C-R 
 
CTACGAAGTTCGGCAGTGGCTCAGCTTGCGCA
CGGAGATGCAGGACGTCAG CAT GGTG 
 
 
LKB1K548A-F 
 
TCGGCACTGAAGAGGGCCGCCAAGAAGCTGA
CGTCC 
 
 
LKB1Delta537-
551-F 
 
GGTAGCAGAGAGGAGGCG 
CTGACGTCCTGCATCTCC 
 
 
LKB1R547AK548
A-F 
 
TCGGCACTGAAGGCGGCCGCCAAGAAGCTGA
CGTCC 
 
 
LKB1K539AK540
AK541A-F 
 
GAGGAGGCGCCCGTCGCCGCGGCGGGATCG 
GCA CTG 
 
 
LKB1K550AK551
A-F 
 
GCA CTG AAG AGG CGC GCT GCG GCG CTG 
ACG TCC TGC 
 
 
LKB1R547AR548
AK550AK551A-F 
 
TCG GCA CTG AAG GCG GCC GCC GCG GCG 
CTG ACG TCC TGC 
 
 
LKB1 335-F 
 
CACC ATGACGGGCCAAGGTTCT 
 
 
LKB1 512-F 
 
CACC ATG CACACCTACGAACCGCC 
 
 
LKB1-536-C-F CACC ATG GCGCCCGTCAAGAAG  
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Name Sequence 5’ → 3’ Description 
LKB1R547AR548
AK550AK551A-F 
 
TCG GCA CTG AAG GCG GCC GCC GCG GCG 
CTG ACG TCC TGC 
 
LKB1K546AR547
AR548AK550AK5
51A-F 
 
TCG GCA CTG GCG GCG GCC GCC GCG GCG 
CTG ACG TCC TGC 
 
 
LKB1 
K205K206K207A-
F 
 
GTCAAGATCCTGACTGCCGCGGCGTTGCGCCG
GATT 
 
 
LKB1 R206A-F 
 
GTCAAGATCCTGACCAAGGCGAAGTTGCGCC
GGATT 
 
 
LKB1 K205-210A-
F 
 
CAAGATCCTGACTGCCGCGGCGTTGGCCGCGA
TTCCCAACGGCG 
 
 
M13 for GTAAAACGACGGCCAG 
Sequencing of 
inserts in 
pENTR vector 
M13 rev CAGGAAACAGCTATGAC 
Sequencing of 
inserts in 
pENTR vector 
 
MBP for GCGTGCTGAGCGCAGGTATTAACGCCGC 
Sequencing of 
destination 
vectors 
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3.1.7 Plasmids 
Plasmids were obtained from Amersham Pharmacia Biotech (now GE Healthcare Life 
Sciences), Invitrogen, Murphy lab (Carnegie Institution for Science, Department of 
Embryology, Baltimore, USA) and New England Biolabs (Frankfurt am Main, 
Germany). 
 
Table 3-8: Plasmids 
Plasmid Description Source/Reference 
pENTR/D-TOPO 
 
Entry vector for Gateway cloning, 
kanamycin resistance 
 
Invitrogen 
pGEX-4T-1 
Vector for expression of GST 
fusion 
proteins in E. coli, ampicilin 
resistance 
Amersham Pharmacia Biotech 
 
pGGWA 
Destination vector for expression 
of GST 
fusion proteins in E. coli, ampicilin 
resistance 
Invitrogen 
pMAL-c2X 
Expression of Maltose binding 
protein, ampicilin resistance 
New England Biolabs 
pMGWA 
Destination vector for expression 
of MBP 
fusion proteins in E. coli, ampicilin 
resistance 
Invitrogen 
pPGW 
Expression vector for Drosophila 
cells, UASp promoter, N-terminal 
GFP tag, ampicilin resistance 
Murphy lab 
pPWH (attB) 
GAL4-driven somatic and female 
germline expression in vivo 
 
Murphy lab 
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Plasmid Description Source/Reference 
pTGW (attB) 
Expression vector for Drosophila 
cells, UASt promoter, N-terminal 
GFP tag, ampicilin resistance, 
GAL4-driven somatic expression  
Murphy lab, Baltimore, USA 
 
 
3.2 Molecular biology methods 
 
3.2.1 Polymerase chain reaction (PCR) 
DNA fragments were amplified by the PCR method (Mullis and Faloona, 1987) 
according to standard protocols. PCR reactions were done in 25 µl or 50 µl total 
reaction volume. Typically 20-100 ng/µl of plasmid DNA were mixed with 200 nM of 
forward/reverse primer, 250 µM of each dNTP (Bioline) and 0,02 µl polymerase per µl 
of total volume in the corresponding reaction buffer. For most applications Pfu S 
polymerase (lab internal) was used, for site-directed mutagenesis Accuzyme (Bioline, 
London, UK) was utilized. 
 
Table 3-9: Standard PCR program 
Step Temperature Duration (minutes:seconds) 
1. Initial denaturation 95°C 5:00 
2. Denaturation 95°C 0:30 
3. Annealing 
50-70°C, depending 
on primer pair 
0:30 
4. Elongation 72°C 
Depending on construct 
length (1 min/kb) 
Repeat steps 2-4 35 times 
5. Final elongation 72°C 5:00 
6. Hold 12 °C  
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The thermocycler “Master Cycler Nexus Gradient”(Eppendorf, Hamburg, Germany) 
was used for running the PCR programs, a standard program is shown in Table 3.9. 
PCR products were purified after gel electrophoresis (3.2.2) using the “Nucleo 
Spin
®
Gel and PCR Clean-Up” kit (Machery-Nagel) according to manufacturer’s 
instructions and eluted in 30 µl distilled water.  
 
3.2.2 Agarose gel electrophoresis 
For the analysis of DNA fragments resulting from enzymatic digestion of DNA or PCR, 
samples were separated in 1% (or 2% for fragments < 500bp) agarose gels containing 
TAE buffer and 0.5 µg/ml ethidium bromide. Samples were mixed with the respective 
amount of 6X loading dye solution (Thermo Scientific). To estimate the size of the 
separated fragments, 10 µl of GeneRuler 1 kb DNA Ladder (Thermo Scientific) were 
used in a parallel lane. The gels were run 20-30 minutes at 140 V. To visualize the DNA 
bands were documented with a UV transilluminator (Intas). 
 
3.2.3 Measurement of DNA concentration 
To determine concentration and purity of isolated DNA, the absorption at 260/280 nm 
was measured with a NanoDrop 1000 spectrophotometer (Thermo Scientific). Since 
double-stranded DNA has an absorption maximum at 260 nm and protein 
contaminations show an absorption at 280 nm, an absorption quotient of 1.8 shows a 
pure DNA solution. Usually the DNA concentration obtained from Midi-preparations 
has been adjusted to 1 µg/µl. 
 
3.2.4 Gateway cloning 
The Gateway
TM 
technology (Invitrogen) has been employed for cloning of genes of 
interest into diverse destination vectors. Vectors of the “Drosophila GatewayTM Vector 
Collection” (Murphy Lab, Carnegie Institution for Science, Department of Embryology, 
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Baltimore) were used for applications in Drosophila cultured cells and to generate 
transgenic flies (see 3.6.2).  
 
3.2.5 pENTR/D-TOPO cloning 
Purified PCR products were introduced into the Entry vector by a topoisomerase-
catalyzed reaction (pENTR/D-TOPO Cloning Kit, Invitrogen). This reaction involves a 
cleavage of the vector DNA by Topoisomerase I, leaving a 5’ overhang, which is 
complementary to the “CACC” sequence at the 5’ end of the forward primers used for 
the amplification of the ORF. The complementary sequences anneal and lead to a 
correct orientation and in-frame integration of the ORF into the vector. The cloning 
reaction was used to transform DH5α cells. The success of the ligation and the correct 
orientation of the integrated ORF were determined by analytical digests with restriction 
endonuclease (Thermo Scientific) according to manufacturer’s instructions. The 
sequence of the insert was verified by sequencing using M13-Fwd and M13-Rev 
primers. 
 
3.2.6 Cloning of potential LKB1 interaction partners 
alpha-spec was cloned from an EST clone and corrected by PCR-based mutagenesis 
(Michael Krahn). β-Spectrin was obtained from Jan Pielage (Fredrich Mischer Institute 
for Biomedical Research, Basel).  
 
3.2.7 Cloning of lkb1::gfp-lkb1 genomic 
The genomic construct of LKB1 was amplified from a pFlyFos vector (FlyFos025349). 
In order to express GFP-tagged recombinant transgenes of lkb1 and several mutant 
versions of lkb1 in an expression level and –pattern that resembles the endogenous 
LKB1 expression, a genomic lkb1 transgene was created. The upstream region of lkb1, 
starting at 2830 bp upstream of the start codon, was amplified by PCR and egfp cloned 
downstream of the endogenous promoter in a pENTR vector (lkb1 genomic pENTR first 
half). In a second pENTR the genomic lkb1 was cloned (lkb1 genomic pENTR second 
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half), which was also used for PCR-based mutagenesis for the creation of mutations. 
Before recombination into a destination vectors, both pENTR were joined by classical 
cloning. 
 
3.2.8 Gateway LR recombination reaction 
Genes of interest were transferred from pENTR/D-TOPO vector into destination vectors 
via the LR recombination reaction.  integrase catalyzes the recombination of an ORF, 
flanked by attL1 and attL2 recombination sites, with attR1 and attR2 recombination 
sites of a destination vector. This exchanges the ORF with the ccdB gene of the 
destination vector. The recombination is direction-specific, because of differences 
between attL1 and attL2 as well as between attR1 and attR2.  
 
Figure 3-1: Gateway LR recombination reaction. Catalyzed by  integrase, attL and 
attR sites are recombined, yielding the expression clone and a byproduct, carrying the 
lethal ccdB gene (figure drawn according to Liang et. al, 2013). 
The recombination was set up by mixing 100 ng of pENTR vector and 90 ng of 
destination vector and adding 0.4 µl of clonase mix. The mixture was incubated for 
25°C for 1 hour, then DH5α chemical competent cells were transformed. Since the ccdB 
gene product is toxic for standard laboratory strains of E. coli, it allows a selection of 
expression clones based on lack of toxicity in addition to the selection by the ampicillin 
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resistance of the destination vector’s backbone (Figure 3-1). Transformants were 
picked, the success of the recombination was determined by analytical digest with 
restriction endonuclease (Thermo Scientific) according to manufacturer’s instructions. 
 
3.2.9 Transformation of chemically competent E. coli cells 
Chemically competent E. coli cells (Table 3-10) were transformed by the following 
procedure: First, the cell solution was thawn on ice, 100-1000 ng (3000-5000ng for 
BL21 Star (DE3) cells) of plasmid DNA were added to 100 µl of competent cell 
solution and this was incubated for 20-30 minutes on ice. Then the cells were 
heatshocked at 42°C for 1 minute on a thermoblock (Eppendorf), cooled on ice for 5 
minutes, 400 µl LB medium were added and the cells incubated for 1 hour at 37°C with 
shaking. After that the cells were plated on prewarmed LB agar plates with the 
appropriate antibiotic for selection. 
Table 3-10: Bacterial strains 
Strain name Genotype Application Source 
DH5α 
80dlacZΔM15, 
Δ(lacZYAargF) 
U169, deoR, recA1, 
endA1, 
hsdR17(rK-,mK+), 
phoA, supE44, -, 
thi-1, gyrA96, relA1 
Amplification of 
plasmid 
DNA 
Invitrogen 
BL21 
F-, ompT, 
hsdSB(rB-, mB-), 
dcm, gal, 
(DE3) 
Expression of 
recombinant 
proteins 
Invitrogen 
BL21 Star™(DE3) 
F– ompT 
hsdSB(rB–, mB–) 
gal dcm rne131  
Expression of 
recombinant 
proteins 
Invitrogen 
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3.2.10 Isolation of plasmid DNA by Alkaline Lysis with SDS 
 
3.2.10.1 Mini Preparation 
To isolate recombinant plasmid DNA from genetically modified bacteria colonies of 
transformed E. coli were inoculated in 2 ml LB medium and incubated at 37°C at 200 
rpm overnight or for 6 hours. The cells were pelleted by centrifugation for 1 minute at 
6000 rpm. For resuspension 200 µl of buffer P1 (including 100 μg/ml RNase A) were 
added. Lysis buffer P2 and after about one minute of incubation neutralization buffer P3 
were added. The mixture was inverted several times and centrifuged for 6 minutes at 
12000 rpm at 4 °C. The supernatant was then transferred to a new Eppendorf tube filled 
with 900 µl pure ethanol, mixed and then centrifuged at 12000 rpm for 12 minutes to 
precipitate the DNA. The supernatant was discarded, the pellet washed with 70% 
ethanol. After 5 minutes of centrifugation at 12000 rpm, the supernatant was discarded 
and the pellet was dried at 65°C in a drying cabinet for 10 minutes. The pellet was 
dissolved in 25 µl ddH2O. 
Strain name Genotype Application Source 
TOP10 
F– mcrA Δ(mrr-
hsdRMS-mcrBC) 
Φ80lacZΔM15 
ΔlacX74 recA1 
araD139 Δ(ara 
leu) 7697 galU 
galK rpsL (StrR) 
endA1 nupG 
Cloning of PCR 
fragments in 
pENTR vector 
Invitrogen 
XL1-Blue  
 
endA1 gyrA96(nal
R
) 
thi-1 recA1 relA1 
lac glnV44 
F'[ ::Tn10 proAB
+
 
lacI
q
 Δ(lacZ)M15] 
hsdR17(rK
-
 mK
+
) 
Site-directed 
mutagenesis 
Stratagene 
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3.2.10.2 Midi Preparation 
 For the isolation of larger amounts of DNA plasmid DNA was purified with the 
NucleoBond 
®
PC 100 kit (Machery-Nagel), but by the same principle as the mini 
preparations (alkaline lysis with SDS), according to the manufacturer’s protocol. In 
brief, 50 ml overnight culture were centrifuged, the pellet resuspended in 4 ml S1 
resuspension-buffer (provided with the kit), 4 ml S2 lysis-buffer were added, mixed, 
incubated for 3 minutes at room temperature 4 ml S3 neutralization-buffer were added, 
the resulting solution inverted several times. After 5 minutes of incubation on ice it was 
inverted again and centrifuged for 8 minutes at 10000 rpm at 4°C. The columns were 
prepared by addition of 2.5 ml N2 equilibration-buffer. The supernatant of the solution 
was filtered with a cellulose filter and loaded onto the column. After the lysate solution 
passed through the column, it was washed by filling up the column with N3 (washing 
buffer). The DNA was then eluted with 5 ml N5 elution-buffer. 3.5 ml Isopropanol were 
added and mixed by inverting. For the precipitation the solution was centrifuged 30 
minutes at 12000 rpm at 4°C. The supernatant was discarded; the pellet washed with 5 
ml 70% ethanol for 10 minutes at 12000 rpm. The pellet dried for 10 minutes (or until 
no liquid could be seen) at 65°C in a drying cabinet. To dissolve the pellet 100 µl of 
sterile distilled water were added, the concentration was measured with a NanoDrop 
1000 Spectrophotometer and adjusted to 1 µg/µl. 
 
3.2.11 Site-directed mutagenesis 
The site-directed mutagenesis kit QuikChange (Agilent Technologies) was employed 
for adding point mutations in ORFs cloned into pENTR. The pENTR vector was 
amplified with a primer containing the desired mutation and a silent mutation that can 
be used to identify the mutated vector by adding a restriction site to the given vector. 
Using 20 ng of entry clone and 125 ng of the primer, the site directed mutagenesis was 
performed in a “Master Cycler nexus gradient” (Eppendorf, cycler program see Table 3-
11). The template DNA was removed by digestion with 1 µl DpnI for 1 hour at 37°C. 
The DH5α cells were transformed with 2 µl of the solution (3.2.9). 
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Table 3-11: Site directed mutagenesis program 
Step Temperature (°C) 
Duration 
(minutes:seconds) 
1) Initial denaturation 95 0:30 
2) Denaturation 95 0:20 
3) Annealing 55 0:20 
4) Elongation 68 3:00 
Repeat steps 2-4 25 times 
5) End of the reaction 37  
3.2.12 Sequencing of DNA 
During the first year of this work sequencing reactions were set up as follows: 300 ng of 
plasmid DNA were mixed with 8 pmol of sequencing primer, 1.5 µl sequencing buffer 
and 1.5 µl sequencing mix added and filled up with sterile water to 10µl. The PCR 
program for sequencing reaction is shown in Table 3-12. 
Table 3-12: PCR program for sequencing reactions 
Step Temperature (°C) 
Duration 
(minutes:seconds) 
1) Initial denaturation 96°C 2:00 
2) Denaturation 96°C 0.20 
3) Annealing 55°C 0:30 
4) Elongation 60°C 4:00 
Repeat steps 2-4 26 times 
5) End of the reaction 12°C  
 
After the PCR reaction the mixture was transferred to a new tube, 1 µl of 125 mM 
EDTA, 1 µl of 3 M Sodium acetate and 50 µl of 100% ethanol were added, the sample 
incubated for 5 minutes. For precipitation the sample was centrifuged for 15 min at 
13000 rpm, the supernatant removed and the pellet washed with 70% ethanol. Then 5 
minutes of centrifugation at 13000 rpm were done, the supernatant removed and the 
pellet air-dried. The pellet was then dissolved in 15 µl of HiDi (Applied Biosystems). 
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Analysis of sequencing reactions was done by in-house sequencing service in the 
Department of Developmental Biochemistry, Ernst-Caspari-Haus, GZMB, Göttingen. 
For external sequencing reactions were set up using 1.2 µg of the plasmid, 30 pmol of 
the sequencing primer filled up to 15 µl and sent to Seqlab/Microsynth (Göttingen, 
Germany). 
 
3.2.13 Isolation of genomic DNA from flies 
Adult flies were collected in an 1.5 ml reaction tube and frozen for 10 minutes at -80°C. 
Then the flies were ground with in 200 µl buffer A with a biovortexer, another 200 µl of 
buffer A were added and the grinding continued until only cuticles remained visible. 
Afterwards it was incubated for 30 minutes at 65°C. Then 800 µl of potassium 
acetate/lithium chloride solution were added and the mixture incubated on ice for 30 
minutes and centrifuged for 15 minutes at 13000 rpm. 1 ml of the supernatant was 
transferred to a new tube and 600 µl Isopropanol mixed to it for precipitation at 13000 
rpm for 15 minutes. The supernatant was then discarded, the pellet washed in 200 µl 
70% ethanol and centrifuged for 10 minutes at 13000 rpm. The pellet was then dried 
and resuspended in 150 µl TE buffer. 
 
3.3 Drosophila cell culture 
 
3.3.1 Culture and transfection of Schneider 2 cells 
Schneider 2 (S2) cells are an immortalized embryonic cell line (Schneider, 1972), the 
S2R+ cell line is known to express the Wingless receptor Frizzeled-2, unlike other 
known S2 cell lines and therefore reacts to wingless (Yanagawa et al.,1998). Cultured 
cells were maintained in flasks of either 25 cm² or 75 cm² at 25°C in Complete 
Schneiders’s Medium (PAN biotech). Cells were split once or twice per week. For 
transfections S2R cells were split to 6 well plates 24 hours before transfection (usually 
0.6 – 2 x 106 cells in 2 ml). For immunostaining a sterile coverslip was placed in each 
well before adding the cells to the wells.  
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S2 cells were transfected with FuGENE HD Transfection Reagent (Roche). For this 2 
µg plasmid DNA were diluted in 94 µl sterile water or Schneider’s Medium without 
serum, mixed and 4 µl FuGENE added to the solution and incubated for 15 minutes at 
room temperature. All reagents were warmed to room temperature before mixing. After 
15 minutes of incubation the transfection mixture was added to the cell suspension. 
After transfection the cells were incubated at 25°C for 2-7 days. For GFP-tagged 
recombinant proteins the transfection rate was checked by fluorescence microscopy.  
 
Table 3-13: S2 cell lines 
Strain Further Information References 
S2R Drosophila 
Schneider Cells 
--- 
AG Wodarz, 
Göttingen 
S2R
+
 Drosophila 
Schneider Cells 
cell culture line established from 
OregonR embryos  
(Schneider, 1972) 
AG Sprenger, 
Regensburg 
 
3.3.2 Leptomycin B assay 
To inhibit the protein nuclear export factor embargoed (a homolog of human CRM1/ 
Exportin-1), which mediates the transport of proteins carrying leucine-rich nuclear 
export signals (NES) from the nucleus to the cytoplasm, cells were incubated with a 
1:100 dilution of Leptomycin B solution (Sigma-Alldrich) in S2 cell culture medium.  
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3.4 Histology 
 
3.4.1 Fixation and immunostaining of Schneider 2 cells  
To prepare transfected cells for confocal microscopy (3.4.6) they were fixed with 4% 
formaldehyde 15 minutes at room temperature in PBS. Prior to fixation, the medium 
was sucked of and the cells washed with PBS. An incubation with 5% NHS in PBT was 
performed to block unspecific binding. Afterwards the cells were incubated with the 
staining solution containing the first and secondary antibody in PBT with 5% NHS for 2 
hours at room temperature. To stain DNA a DAPI staining was performed with a 
solution of 1:1000 DAPI (5 µg/ml) in PBT for 10 minutes, and washed two times with 
PBT for 10 minutes. Finally the cells were embedded in 35 µl Mowiol. 
 
3.4.2 Fixation and immunostaining of embryos 
For the collection of embryos, flies were kept in either small or big cages with apple 
juice agar plates with yeast paste (made from blocks of baker’s yeast with water) at the 
bottom. To collect the eggs, the plates were first removed from the cage, rinsed with 
water and the eggs released from the bottom with a brush. After that about the same 
volume of 5% sodium hypochlorite was added and the embryos incubated for 4-5 
minutes, until the chorion was dissolved. The resulting slurry was filtered through a 
sieve with a vacuum pump and washed extensively with water to collect and clean the 
embryos. 
After the collection and dechorionization the embryos were fixed with 3 ml of 4% 
formaldehyde in PBS with 3 ml heptane on top in a glass vial and incubated on a rocker 
for 20 minutes. The lower phase was then removed and 3 ml methanol added. The 
embryos were washed three times with methanol and stored at -20°C for at least one 
hour. 
Fixed embryos were washed three times for 20 minutes with PBT on a rocker. To block 
unspecific binding the embryos were incubated with PBT with 5% NHS for 30 minutes. 
After that the embryos were incubated with the primary antibodies in PBT with 5% 
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NHS and incubated overnight at 4°C. Then three washing steps with PBT for 20 
minutes were done. The secondary antibodies, which were tagged with fluorescent 
markers, were then applied 1:200 in PBT with 5% NHS for two hours at room 
temperature on a rocker. Afterwards the embryos were washed again three times for 20 
minutes with PBT, the first washing step includes a staining with DAPI (solution 
applied 1:1000). Finally the embryos were transferred to a microscope slide and 
embedded in Mowiol. 
 
3.4.3 Fixation and immunostaining of ovaries 
Newly hatched flies were put in cages with apple juice agar plates and yeast paste for 
two days to enhance the development of ovaries in the females. For dissection the 
females were anesthetized with carbon dioxide, the ovaries dissected with forceps, 
collected in 900 µl of PBS 1.5 ml eppendorf tubes and fixed with 110 µl of 37% 
formaldehyde. After three washing steps with PBT, the ovaries were blocked and 
permeabilized by incubation with PBS with 1% Triton X-100 and 0.5% BSA for 2 
hours. To separate the ovarioles, the ovaries were then pipetted up and down with a 
1000 µl pipette tip. The primary antibodies were applied in PBS with 0.3% Triton X-
100 overnight at 4°C on a rocker. Then the eggchambers were washed again three times 
with PBT, blocked for 2.5 hours in PBS with 0.1% Triton X-100 and 10% NHS. 
Afterwards the secondary antibodies were applied in a 1:200 dilution in PBS with 0.1% 
Triton X-100 and 10% NHS. Subsequently the eggchambers were stained with DAPI 
for 20 minutes (DAPI-solution 1:1000 in PBT) and washed two times with PBT. Finally 
the eggchambers were transferred to a microscope slide and embedded in Mowiol. 
 
3.4.4 Fixation and immunostaining of larval brains and imaginal discs 
Larvae of the L3 wandering stage were dissected in PBS and the brains fixed for 20 
minutes in 4% formaldehyde in PBS on a rocker. After three washing steps with PBS 
with 0.1% Triton X-100, the brains or imaginal discs were permeabilized and blocked 
for 1 hour in PBS with 1% Triton X-100 and 5% NHS. The staining procedure was 
performed as described for the embryos (1.5.2). 
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3.4.5 Detection of apoptosis in imaginal discs 
The hallmark of apoptosis is DNA degradation. In order to detect apoptosis TUNEL 
(TdT-mediated dUTP-X nick end labeling)-assays were made with the “In Situ Cell 
Death Detection Kit, TMR red” (Roche). This method uses modified nucleotides (in this 
case TMR-dUTP) to label free 3’-OH termini of DNA breaks (nicks) in an enzymatic 
reaction. This reaction is catalyzed by terminal deoxynucleotidyl transferase (TdT) and 
polymerizes the modified nucleotides to the 3’-end of single-and double-stranded DNA.  
To detect apoptosis in imaginal discs they were, after staining with primary and 
secondary antibodies, incubated for one hour at 37°C with a mixture of 45 µl of Label 
Solution and 5 µl of Enzyme Solution. After this the embryos were washed and stained 
with DAPI as described above. Since the red fluorescent TMR-dUTP is incorporated 
into damaged DNA strands it enables detection of apoptotic cells by fluorescence 
microscopy.  
 
3.4.6 Confocal microscopy 
Images were made on a laser scanning confocal microscope (LSM 510 Meta using 45x 
0,8 NA Plan Neofluar or 63x 1.4 NA Plan Apochromat objectives or LSM 710 Meta 
using either 25xNA 0.8 or 63x NA 1.2 water objectives and ZEN 2010 software (Carl 
Zeiss). Images were processed using Photoshop CS5 (Adobe) and ImageJ 
(version1.43m, NIH, USA). 
 
3.4.7 Preparation and imaging of wings 
Wings were prepared for light microscopy by dissection of adult flies, benumbed by 
carbon dioxide in ethanol using forceps. The wings were spread on a microscope slide 
and mounted using DPX Mounting medium (Sigma-Alldrich). The wings were imaged 
by transmitted light microscopy using a EC Plan-Neofluar 2.5x/0.075 Pol M27 
objective (Zeiss).and an AxioCam MRc camera (Zeiss).  
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3.5 Biochemical methods 
 
3.5.1 Protein extraction from embryos 
Embryos were collected, their chorion was removed and they were washed as described 
in 3.4.2 and collected in 1.5 ml eppendorf tubes in 1000 µl water. Then they were 
centrifuged at 12000 rpm for 1 minute and the supernatant discarded. After this 
embryos were homogenized for 30 seconds with a biovortexer (Roth; for small amounts 
just the tip of the device was used to squash the embryos) in lysis buffer (TNT with 
1:500 of PMSF, Aprotinin, Leupeptin and Pepstatin). If the phosphorylation status of 
the protein of interest had to be preserved, 1:100 of phosphatase inhibitor cocktail 
(CALBIOCHEM) and 1:500 of cantharidin solution were added. After 20 minutes 
incubation on ice the lysate was centrifuged for 10 minutes at 12000 rpm, 4°C, the 
supernatant transferred into a new eppendorf tube and 1 µl taken for measuring the 
protein content of the supernatant.  
 
3.5.2 Measurement of protein concentration 
The total concentration of protein in solutions was estimated according to the Bradford 
method with 200 µl Roti-Quant reagent (Roth), which was mixed 1:5 with water and 1-
10 µl of the protein solution (dependent on the expected concentration). The absorption 
was measured at 595 nm with a spectrophotometer with an integration time of 2 
seconds. For calibration a curve with BSA standard was used. 
 
3.5.3 Co-Immunoprecipitation 
For co-immunoprecipitation embryos were lysed in NP-40 buffer with freshly added 
protease inhibitors (Pefabloc 200 μg/ml, Pepstatin 2 μg/ml, Aprotinin 2 μg/ml, 
Leupeptin 2μg/ml (Roche) using a biovortexer (Roth). After 20 minutes of incubation at 
4°C the sample was centrifuged for 10 minutes at 12000 rpm, 4°C. The supernatant was 
then transferred to a new tube, a 10 µl aliquot taken for the input sample, which was 
mixed with 10 µl 2x SDS loading buffer. The concentration of protein was measured 
and adjusted to the lowest protein concentration by diluting the higher concentrated 
Material and Methods 
 
 
 
50 
 
samples with lysis buffer. The guinea pig anti-LKB1 antibody was added to the lysates 
in 1:500 dilution, they were placed on a rocker at 4°C for 30 minutes. Then 20 µl of 
Protein A sepharose beads were added and the samples shaken for 1.5 hours at 4°C. The 
beads were then spun down by centrifugation at 6500 rpm for one minute and washed 
three times with NP-40 buffer. After removing excess liquid, 16 µl of 2X SDS loading 
buffer were added to the beads and the sample boiled at 95°C for 5 minutes. 
 
3.5.4 SDS-polyacrylamide gel electrophoresis 
Denaturing discontinuous SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was 
used to separate protein samples electrophoretically. 10% or 7.5% resolving gels were 
used with a stacking gel according to Table 3-14. 
 
Table 3-14: Acrylamide gel recipe 
 
Gel Component 
Resolving Gel Acrylamide 
1M Tris-
HCl pH 8.8 
Water 
10% 
SDS 
10% 
APS 
TEMED 
7.5% Gel 3.75 ml 5.75 ml 4.9 ml 150µl 150µl 6µl 
10% Gel 5 ml 5.75 ml 3.65 ml 150µl 150µl 6µl 
Stacking Gel  Acrylamide 
1M Tris-
HCl pH 6.8 
Water 
10% 
SDS 
10% 
APS 
TEMED 
5% 830µl 630µl 3.5 ml 50µl 50µl 5µl 
Numbers given for two gels. 
 
Protein samples were mixed 1:1 with 2X SDS loading buffer or 1:5 with 6X SDS 
loading buffer and boiled for five minutes and centrifuged to spin down the sample. 
After that the samples were loaded into the pockets of the gel. 3 µl of PageRuler 
Prestained Protein Ladder (Thermo Scientific) were loaded as molecular weight size 
marker. Gels were usually run for 1 hour in SDS running buffer. 
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3.5.5 Western Blot 
Protein samples were separated by SDS-PAGE (3.5.4) and transferred to nitrocellulose 
membrane with the Rotiphorese
®
 PROclamp MINI Tank-Blotting-System (Roth) 
according to manufacturer’s instructions. For this transfer buffer with 20% methanol 
added was used, the transfer took place at 100 V for 1 hour at 4°C. The success of the 
transfer could be tested by staining with Ponceau Solution, which was then removed by 
washing with TBST. Blocking of the membrane to prohibit background signal was done 
in blocking buffer (1% BSA, 3% skim milk powder in TBST). 
 
3.5.6 Protein purification 
For the expression of tagged protein by bacteria 50-300 ml LB medium were inoculated 
with 1-6 ml overnight culture of BL21 or BL21 Star bacteria carrying the target 
plasmid. The cultures were shaken at 200-250 rpm at 37°C, until they reached mid-log 
phase at an OD600 of 0.6. To induce expression of the recombinant protein IPTG was 
added to a final concentration of 0,5 mM, 2% of pure ethanol and 3% of potassium 
dihydrogenphosphate were added to aid the induction. The cultures were chilled on ice 
for a short time and incubated for 16-18 hours at 18°C. The bacteria were harvested by 
centrifugation at 6000 rpm for 5 minutes. The resulting pellet was frozen at -80°C for 
30 minutes and resuspended in half to one volume of the culture of LEW buffer 
containing 1% Triton X-100, proteinase inhibitors, and 10 mM mercaptoethanol. Then 
the supspension was incubated for 30 minutes at 4°C and in most cases also sonicated (6 
cycles of 15 seconds). The lysates were then cleared at 12000 rpm for 15 minutes at 
4°C.  
GST fusion proteins were purified by adding 10 µl of Protino Glutathione Agarose 4B 
beads (Machery-Nagel) for each milliliter of supernatant and incubated for two hours at 
4°C. For MBP fusion proteins 10 µl of Amlyose Resin beads (New England BioLabs) 
were added for each milliliter of supernatant and incubated for two hours at 4°C. The 
column or beads were washed once with LEW, once with LEW with 2 M sodium 
chloride and then again with LEW. After each washing step the beads were centrifuged 
for 1 minute at 6000 rpm. GST fusion proteins were eluted with 30 mM Gluthatione in 
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50 mM TRIS-HCl pH 7.5 with 150 mM NaCl. MBP fusion proteins were eluted with 20 
mM Maltose in 50 mM TRIS-HCl pH 7.5 with 150 mM NaCl. 
 
3.5.7 GST-Pulldown assay 
To analyze direct interactions between proteins in vitro, a GST fusion protein pulldown 
assay was used. Beads for the pulldown were preincubated overnight with 500 µl of 5% 
BSA solution in incubation buffer at 4°C to block unspecific binding. Proteins were 
expressed in BL21 Star cells and purified using respective beads and elution buffers 
(3.5.6). 1 µM GST-fusion protein solution and 1 µM of MBP-fusion protein solution, 
which were before dialyzed overnight using incubation buffer buffer (20 mM Tris pH 
8.0, 100 mM potassium chloride, 10 mM magnesium dichloride, 1mM DTT (added 
immediately before use)), were adjusted to a total volume of 60 µl with incubation. in a 
1.5 ml reaction tube and incubated for 1 hour at 4°C in ice with occasionally snipping. 
Then 10 µl of preincubated Protino Glutathione Agarose 4B beads (Machery-Nagel) 
were added and incubated for 1 hour at 4°C on ice with occasionally snipping. The 
beads were then collected by centrifugation at 6000 rpm for one minute and the 
supernatant discarded. Afterwards the beads were washed five times with 500 µl wash-
buffer (20 mM Tris pH 8.0, 20 mM potassium chloride, 0.1 % Triton X-100 and 1 mM 
DTT added immediately before use) and subsequent centrifugation at 6000 rpm for one 
minute and removal of the supernatant. Finally the supernatant was removed except for 
about 20 µl of total volume including the volume of the beads. Then 5 µl of 6X SDS 
loading buffer were added and the sample boiled for 5 minutes at 95°C. The samples 
were analyzed by Western blot. 
 
3.5.8 Lipid overlay assay 
To determine lipid binding specificity of the LKB1 C-terminus PIP Strips (Echelon 
Biosciences, USA) were used according to the manufacturer’s protocol. In brief, the 
membrane was first blocked in blocking buffer (1x TBS, 0.1% Tween, 3% BSA, the pH 
of was adjusted to 7.4) for one hour. After that, the membrane was incubated overnight 
with 1µg/ml of MBP-fusion protein or MBP as control in blocking buffer. The 
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membrane was washed three times in TBS with 0.1% Tween and incubated with anti-
MBP antibody in blocking buffer for one hour. Afterwards it was washed as previously 
described and incubated for one hour with HRP-coupled secondary antibody. The 
membrane was again washed three times and bound protein detected by a 
chemiluminescence reaction using the “Super Signal West Pico Chemiluminescence 
Substrate” kit (Thermo Scientific). 
 
3.6 Fly genetics 
 
3.6.1 Fly breeding 
Fly stocks were kept at 18°C, 21°C or 25° with standard food (Ashburner, 1989) with 
sprinkles of dry yeast on top. The vials where changed in intervals of three to five week 
at 21°C. For the collection of embryos, flies were kept in either small or big cages with 
apple juice agar plates with yeast paste (made from blocks of baker’s yeast with water) 
at the bottom.  
The standard medium was made of 712 g cornmeal, 95 g soya flour, 168 g dry yeast, 
450 g malt extract, 150 ml 10% Nipagin solution (700 ml 99% ethanol, 300 ml H2O, 
100 g Nipagin), 45 ml propionic acid, 50 g agar, 400 g sugar beet syrup, solved in 9.75 l 
distilled water. 
 
3.6.2 Generation of transgenic flies 
For the generation of transgenic flies the ɸC31 integrase system was utilized. It allows a 
site-specific integration of transgenes into specific loci on the genome of flies carrying 
landing sites integrated into their genome. ɸC31 integrase mediates recombination 
between two 34 bp attachment sites (attB in the donor plasmid and attP in the landing 
site). This recombination creates two different sites (attR and attL), which cannot serve 
as functional substrates for the integrase, making the reaction unidirectional (Figure 3-
2). The used fly lines (P{nos-phiC31\int.NLS}X, P{CaryP}attP25C and P{nos-
phiC31\int.NLS}X, P{CaryP}attP68A) express ɸC31 integrase under the control of the 
nanos regulatory elements to aid germline transformation. The integrase further has a C-
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terminal nuclear localization signal attached to enhance integration (Bischof et al., 
2007). Since the position of the transgene is controlled, all constructs integrated into the 
same locus can be directly compared (Groth et al., 2004).  
 
Figure 3-2: Integration mediated by ɸC31 integrase. ɸC31 integrase mediates the 
unidirectional recombination between the attB site of the donor plasmid and attP site of 
the landing site, creating an attL site and an attR site while integrating the transgene 
(figure drawn according to http://www.systembio.com/phic31). 
Transgenes were introduced into the germline by microinjection of integration vector 
DNA into the posterior of preblastoderm embryos like described by Bachmann and 
Knust, 2008. In brief, 20 µg of plasmid DNA were added to 10X-injection buffer (5 
mM KCl, 0.1 mM sodium phosphate, pH 6.8) and water to a final volume of 50 µl. 
Before use the solution was centrifuged for 30 minutes. Dechorionated embryos of the 
fly line carrying the desired landing site were lined up on a block of apple juice agar and 
transferred to a coverslip coated with “embryo glue”. The DNA solution was injected 
into the posterior end of the embryos with an Femptotips
®
II microinjection capillary 
(Eppendorf) by micromanipulator InjectMan NI2 (Eppendorf, Hamburg, Germany). 
Afterwards the injected embryos were covered by 10S Voltalef oil at 18°C for 48 hours 
before the hatched larvae were collected into Drosophila vials. Hatched adults were 
crossed to w
-
; Gla/CyO flies for the transgenic fly selection. Vectors of the “Drosophila 
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Gateway
TM
 Vector Collection” (Murphy Lab, Carnegie Institution for Science, 
Department of Embryology, Baltimore) were used to generate transgenic flies (Table 3-
8). 
 
3.6.3 The UAS-GAL4 system 
The UAS-GAL4 system is a commonly used binary expression system in Drosophila 
research. It utilizes the yeast transcription factor GAL4, expressed under control of a 
known promoter that binds to an upstream activating sequence (UAS). This binding 
activates gene expression in a region downstream of this sequence (Brand and 
Perrimon, 1993). In this study this system was used to ectopically overexpress genes of 
interest in time-, tissue- and cell-specific patterns. 
 
3.6.4 FLP/FRT- mediated recombination 
FLP recombinase mediates recombination between two FRT sites on homologous 
chromosomes. It has been transferred from yeast into the Drosophila genome to 
catalyze site-specific recombination (Golic and Lindquist, 1989). The FLP (Flipase)/ 
FRT (FLP recombinase-target) technique can be utilized to create mutant clones in both 
germline and somatic Drosophila cells by mitotic recombination (Theodosiou and Xu, 
1998). In this study it was used to create clones of homozygous mutant cells in 
otherwise heterozygous follicle cell epithelia (Figure 3-3). The FLP-recombinase was 
expressed under control of a heatshock promoter, which allows a temporal control of the 
mitotic recombination by inducing a heatshock of 1.5-2 hours length at 37°C at specific 
time points. To create clones of different sizes, the heatshock was induced during larval 
stages or during pupal stages. 
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Figure 3-3: Generation of mutant clones by mitotic recombination. A mutant allele 
of the gene of interest and a wild type version of the chromosome can, catalyzed by 
FLP, recombine during mitosis, which can give rise to homozygous daughter cells 
(figure drawn according to Tabata, 2001). 
 
3.6.5 Fly lines 
Fly lines were either created by FLP/FRT-mediated germline transformation or taken 
from various sources (reference in Table 3-15). 
Table 3-15: Fly lines 
Stock  Description Reference 
arm-Gal4 GAL4 driver line 
Bloomington 
#1560 
Cu2-Gal4 
Gal4 driver line, 
expression in follicle 
cells from stage 8, 2nd 
chromosome 
Trudi 
Schüpbach 
 
da-Gal4 
Gal4 driver line, 
ubiquitous expression 
Bloomington 
#5460 
Material and Methods 
 
 
 
57 
 
Stock  Description Reference 
in daughterless gene 
pattern, 3rd 
chromosome 
Gla/CyO 
Second chromosome 
balancer line, curly 
wings 
Krahn lab 
stock collection 
hsFlp;; α-Spec 
FRT80A/TM3 
 
Mutant  
If/F; LKB1
x5
/TM6 
 
Mutant, double balanced  
If/F; lkb1::GFP-
LKB1 genomic 
@99F/TM6 
 
LKB1 transgene; double 
balance 
 
LKB1 RNAi 
VALIUM22  
 
RNAi 
 
#35151 
Made by 
Transgenic 
RNAi Project, 
works in 
germline 
 
lkb1::GFP-LKB1 
C564A genomic 
@99F/TM6 
 
LKB1 transgene 
 
lkb1::GFP-LKB1 
C564A 
genomic/CyO; 
MKRS/TM6 
 
LKB1 transgene; double 
balance 
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Stock  Description Reference 
lkb1::GFP-LKB1 
genomic @25C/F 
 
LKB1 transgene  
lkb1::GFP-LKB1 
genomic @25C/F; 
LKB1x5/TM6 
 
LKB1 transgene 
 
lkb1::GFP-LKB1 
genomic @99F/TM6 
 
LKB1 transgene  
lkb1::GFP-LKB1 
genomic 25C/CyO 
 
LKB1 transgene 
 
lkb1::GFP-LKB1 
ΔLB genomic 
25C/CyO 
 
LKB1 transgene 
 
LKB1
x5 
FRT82B 
/TM3-tw-GFP 
 
Mutant 
Allele from Lee 
et al., 2006 
MKRS/TM6b 
Third chromosome 
balancer line 
Krahn lab stock 
collection 
MTD gal-4   
UASp::LKB1   
UASt::GFP-LKB1 
@25C C564A/F 
 
LKB1 transgene 
 
UASt::GFP-LKB1 
@25C D317A 
"KD"/CyO 
LKB1 transgene 
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Stock  Description Reference 
 
UASt::GFP-LKB1 
@25C K201M 
"KD"/CyO 
 
LKB1 transgene 
 
UASt::GFP-LKB1 
@25C/CyO 
 
LKB1 transgene  
UASt::GFP-LKB1 
ΔLB/CyO 
 
LKB1 transgene  
Ubi::GFP-KB1 512-C 
@25C/Gla CyO 
 
LKB1 transgene 
 
Ubi::GFP-LKB1 
@25C/CyO 
 
LKB1 transgene 
 
Ubi::GFP-LKB1 
C564A @25C/(CyO) 
 
LKB1 transgene 
 
Ubi::GFP-LKB1 
C564A @99F /(TM6) 
 
LKB1 transgene  
Ubi::LKB1 C564A 
@25C/CyO 
 
LKB1 transgene  
white- 
(w1118) 
White eyes 
Bloomington 
#5905 
β-Spec0 
FRT19A/FM7; 
Mutant, double balanced  
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Stock  Description Reference 
Tft/CyO 
 
β -Spec0FRT/FM7-
GFP; lkb1::GFP-
LKB1 genomic 
@25C/F  
 
LKB1 transgene; β-spec 
mutant 
 
 
3.6.6 Lethality assay 
The lethality of flies was tested by collecting 100 embryos of the given fly line on an 
apple juice plate with yeast paste and observing them daily to check in which stage of 
their development they died. To avoid drying of the plate, small amounts of tap water 
were added occasionally. Those flies that developed until adulthood were counted as 
survivors. Each experiment was performed three times. 
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4 Results 
 
4.1 Subcellular localization of LKB1 
 
4.1.1 LKB1 localizes to the cortex of epithelial cells and embryonic 
neuroblasts 
GFP-tagged LKB1 has been observed to localize to the cortex of female germ line cells 
and to the lateral membrane in follicle epithelia cells of Drosophila (Martin and St 
Johnston, 2003). In embryonic epithelial cells and embryonic neuronal stem cells 
(neuroblasts, NBs) overexpressed GFP-LKB1 was found along the cell cortex 
(Yamamoto et al., 2008), while the localization of endogenous LKB1 has not yet been 
described in these cell types.  
To examine the expression and subcellular localization of endogenous LKB1 during 
development of Drosophila we raised an antibody against the N-terminus of LKB1 and 
immuno-stained embryos. A ubiquitous expression of LKB1 in the Drosophila embryo 
was observed (Figure 4-1, A). Immunostaining of the early embryo during 
cellularization indicates a maternal contribution of LKB1 (Figure 4-1, B). The antibody 
showed a lack of staining in embryos in which LKB1 expression has been knocked 
down by RNAi, showing the specificity of the antibody (Figure 4-1 D compared to C). 
For this RNAi knockdown experiment an UAS-LKB1 RNAi fly line (carrying the 
vector VALIUM22 P{TRiP.GL00019}attP2) was crossed with a maternal triple driver 
GAL4 fly line (MTD-Gal4) to drive expression of shRNA during oogenesis in the 
germarium, leading to a knockdown of the maternal component of LKB1 and ongoing 
knockdown in the embryo (Staller et al., 2012). Most of the resulting eggs show no sign 
of embryonic development, probably due to defect in oogenesis like described for germ 
line clones (Martin and St Johnston, 2003).  
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Figure 4-1: Characterization of the LKB1 antibody. A-C – Wild type embryos 
stained with an antibody raised against the N-terminus of LKB1. A - Stage 14 embryo 
displays ubiquitous expression of LKB1. B – LKB1 staining in a stage 5 embryo 
revealing a maternal contribution of LKB1, arrows indicate location of furrow cannels. 
C, D – Stage 11 embryos. D – MTD-Gal4 driven RNAi knockdown of LKB1 in 
embryonic epithelium, stage 11. Scale bar in A, 100 µm; scale bart in B-D, 10 µm. 
 
 
Subcellular localization of LKB1 in the embryonic epithelium was analyzed by co-
staining of LKB1, the adherens junction marker DE-Cadherin and the membrane 
skeleton protein α-Spectrin (Figure 4-2, A). LKB1 shows a co-localization with α-
Spectrin in the basolateral cortex of epithelial cells (Figure 4-2, A). In embryonic NBs, 
a cortical localization was observed throughout different phases of their cell cycle 
(Figure 4-2, B-E). While other regulators of asymmetric division in NBs, like the 
apically localized protein Bazooka (Baz) and the adaptor protein Miranda (Mir) exhibit 
a polarized distribution, which is most prominent during metaphase (Figure 4-2, C; 
Wodarz and Huttner, 2003), LKB1 was found symmetrically along the cortex of 
embryonic NBs during different phases of mitosis (Figure 4-2, B-D). This cortical 
localization of endogenous LKB1 in epithelia and NBs is in line with observations from 
overexpressed GFP-LKB1 (Yamamoto et al, 2008). In contrast to this, the localization 
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of endogenous LKB1 in larval NB differs remarkably and displays a diffuse 
cytoplasmic localization (Figure 4-2, E), like previously observed (Bonaccorsi et al., 
2008).  
 
Figure 4-2: LKB1 is localized to the cortex of embryonic epithelial cells and 
embryonic NBs and displays a diffuse cytoplasmic localization in larval NBs. A – 
Embryonic epithelium, stage 12 embryo, LKB1 staining at the basolateral membrane. 
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B, C , D – Neuroblasts on the basal side of the embryonic epidermis in different phases 
of mitosis in stage 9-10 embryos display cortical localization of LKB1. B - Prophase. C 
– Metaphase D – Telophase (asymmetrically dividing cell). E – LKB1 staining is diffuse 
cytoplasmic in NBs of third instar larval brains (both NBs in metaphase). All pictures 
were rotated to display the apical side on top. Scale bars, 10 µm.  

4.1.2 Farnesylation is not crucial for the cortical localization of LKB1 and 
its physiological function 
Farnesylation is a posttranslational modification that adds a 15-carbon isoprenoid group 
to the cysteine of a CAAX motif at the C-terminus of a protein. This process is 
important for protein-protein and membrane-protein interactions and regulates 
localization and function of many proteins (Novelli and D’Apice, 2012). LKB1 has a 
farnesylation motif at the C-terminus that is conserved in Drosophila (Martin and St 
Johnston, 2003). A farnesylation deficient version of GFP-LKB1 has been reported to 
show a weaker cortical localization in the Drosophila germ line than the wild type 
version (Martin and St Johnston, 2003). To examine the role of the farnesylation of 
LKB1 for its subcellular localization in different developmental contexts a point 
mutation of its farnesyl acceptor cysteine (C564) to alanine was performed to create a 
farnesylation deficient mutant. We used the endogenous lkb1 promoter to express GFP-
tagged farnesylation-deficient and wild type genomic LKB1 and created transgenic flies 
with the ΦC31 integrase system, so that both constructs are in the same genomic 
background and should be expressed in equal amounts.  
In the embryonic epidermis GFP-LKB1 localizes to the basolateral cortex of epithelial 
cells (Figure 4-3, F). The cortical localization of GFP-LKB1 in NBs also matches the 
localization of endogenous LKB1 (Figure 4-3, C). The localization of farnesylation 
deficient GFP-LKB1
C564A 
is astonishingly similar to its wild-type counterpart in both 
epithelia and NBs (Figure 4-3 A-D). In the oocyte and the follicle cells surrounding the 
oocyte, the farnesylation-deficient is decisively more cytoplasmic (Figure 4-3, E and F). 
Although the staining of egg chambers suggests an apical localization of GFP-LKB1 in 
follicle cells, expression of GFP-LKB1 utilizing the UASp-promoter in a tissue-specific 
manner reveals a lateral localization in follicle cells (driven by Cu2-GAL4, Figure 4-4 
B) and a cortical localization in the oocyte (Figure 4-5, A).  
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.  
Figure 4-3: Farnesylation is not crucial for cortical localization of LKB1. A-F 
Rescued embryos expressing GFP-LKB1 or GFP-LKB1C564A under control of the lkb1 
promoter. A, B – Embryonic epithelium of stage 12 embryos. C,D – NBs on the basal 
side of embryonic epithelium, stage 10 embryos. E, F – Follicle cells surrounding the 
oocyte. Top is apical in all figures. Scale bars in A and B, 5 µm; in C-F, 10 µm.  
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Figure 4-4: Localization of GFP-LKB1 is strictly lateral in the follicle cell 
epithelium. A – Expression of GFP-LKB1 driven by nos::GAL4 shows strong cortical 
localization in the oocyte. B – Expression of GFP-LKB1 in the follicle cell epithelium 
shows clear lateral localization. Top is apical in both figures. Scale bars, 10 µm. 
 
4.1.3 Farnesylation of LKB1 is necessary for cortical localization of GFP-
LKB1 in S2R+ cells, but not sufficient 
To investigate the regions of LKB1 that are involved in its cortical localization, we 
utilized transient expression of GFP-LKB1 and mutated counterparts using FuGENE 
(Promega) as a transfection reagent in Schneider S2R+ cells. Expressed under control of 
a ubiquitous promoter, GFP-LKB1 is localized almost exclusively to the plasma 
membrane/cell cortex region of transfected S2R+ cells (Figure 4-5, A). A farnesylation 
deficient mutant version (GFP-LKB1
C564A
) is localized mostly cytoplasmic; only a 
fraction is found at the plasma membrane/cell cortex (Figure 4-5, B). To analyze if the 
farnesylation motif is sufficient for targeting GFP to the plasma membrane/cell cortex, a 
fusion protein consisting of GFP and the last 16 amino acids of the C-terminus of LKB1 
(GFP-LKB1
552-C
) was expressed, which was not able to target GFP to the plasma 
membrane (Figure 4-5, C). Farnesylation is generally not sufficient for a stable 
membrane localization of a protein; this usually requires a second signal, which is often 
located at the C-terminus of CAAX proteins (Zhang and Casey, 1996). In accordance, a 
longer C-terminal fragment of the last 55 amino acids of LKB1 (LKB1
512-C
) is able to 
localize GFP to the plasma membrane, albeit showing a nuclear localization that is not 
observed in the full length construct (Figure 4-5, D and A). In the embryonic epithelium 
LKB1
512-C
 is able to localize a GFP fusion protein to the lateral membrane (Figure 4-5, 
J).  
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4.1.4 A polybasic motif at the C-terminus targets LKB1 to the plasma 
membrane 
Since GFP-LKB1
512-C
 was able to localize GFP to the cortex of S2R+ cells and the 
embryonic epithelium (Figure 4-5 D and J), we investigated which region might be 
responsible for supporting the farnesylation motif in localizing LKB1 to the cortex. 
CAAX proteins usually need a second signal in addition to the farnesylation for plasma 
membrane targeting, which is usually either a palmitoylation or the presence of a 
polybasic domain (Zhang and Casey, 1996). 
To test the hypothesis that a polybasic region (amino acids 539-551, Figure 4-5, K) at 
the C-terminus is involved in cortical targeting of GFP-LKB1 in transfected S2R+ cells, 
the effect of a deletion of this region (GFP-LKB1
Δ537-551
) was analyzed, which lead to a 
complete loss of LKB1 cortical localization (Figure 4-5, F). This could also be observed 
in a version of GFP-LKB1, where the positively charged amino acids (lysines and 
arginines) of this region have been mutated to alanines (LKB1
K539A, K540A, K541A, K546A, 
R547A, R548A, K550A, K551A
, termed LKB1
ΔLB
). A mutation of just on side of this region 
(LKB1
K539A,K540A,K541A
, termed LKB1
K539-541A 
or LKB1
K546A, R547A, R548A, K550A, K551A
, 
termed LKB1
546A-551A
) did not alter the localization remarkably (Figure 4-5, G and H).  
For a biochemical characterization of the polybasic region, C-terminal constructs of 
LKB1 (all amino acids from amino acid 335 until the C-terminus) were N-terminally 
tagged with MBP, expressed in E. coli and analyzed in a lipid overlay assay using PIP-
Strips
TM
 (Echelon). PIP-Strips are hydrophobic nitrocellulose membranes spotted with 
15 different lipids. A binding to several phoshpolipids could be detected (PtdIns(5)P, 
PtdIns(4,5)P2, PtdIns(3,4,5)P2 and phosphatidic acid), which was reduced in a mutant 
version, where the polybasic region has been mutated to alanine (Figure 4-6, L). This is 
why we consider the polybasic motif to be a lipid binding domain and termed the 
constructs in which all the basic amino acids (arginine with the symbol “R” and lysine 
with the symbol “K”) of this region were mutated to alanine (symbol “A”) LKB1ΔLB 
(Fig 4-3, K). A phosphodeficient mutation of the PKA phosphorylation site S562, which 
has been reported to be less functional than its wild type counterpart (Martin and St 
Johnston, 2003), did not alter the localization of GFP-LKB1 in S2R+ cells (Fig 4-3, I).  
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Figure 4-5: A polybasic motif at the C-terminus targets LKB1 to the plasma 
membrane. A-I localization of GFP-LKB1 constructs in transfected S2R+ cells. J – 
LKB1512-C is able to target GFP to the lateral membrane of transgenic embryos. Top is 
apical in this figure. K – Alignment of the C-termini of the constructs used in A-I. L – 
Schematic of the arrangement of lipids on a PIP-strip. M - Indication of bound lipids on 
the PIP-strips. N - Coomassie-stained acrylamide gel depicting the purified C-terminal 
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constructs tagged with MBP. PA – phosphatidic acid, PC – phosphatidylcholine.  PE – 
phosphatidylethanolamine, PtdInsP – phosphatidylinositol phosphate. Scale bars, 10 
µm. 
 
When expressed under control of the lkb1 promoter, GFP-LKB1
ΔLB 
localization was 
predominantly cytoplasmic. This was observed in the embryonic epithelium, embryonic 
neuroblasts and the follicle cell epithelium (Figure 4-6, A-C). But with expression 
controlled by the ubiquitin promoter, we see a weakened but still existent cortical 
staining of GFP-LKB1
ΔLB 
compared to GFP-LKB1
 
and GFP-LKB1
C564A 
at the level of 
adherens junctions
 
displayed by DE-Cadherin (Figure 4-6 D-F). The ubiquitin promoter 
is considered to lead to a lower expression level than many promoters used in 
expression studies (Akbari et al., 2009), but the observed GFP-intensity is considerably 
higher than the expression controlled by the lkb1 promoter.  
Rescue experiments with flies homozygous for a lkb1-mutant allele (lkb1
x5
, Lee et al., 
2006) with genomic GFP-LKB1 expressed under control of the lkb1 promoter show a 
reduced viability of GFP-LKB1
ΔLB
 (8% +/-1% survival until adulthood) compared to 
GFP-LKB1 (69% +/- 2% survival until adulthood) and GFP-LKB1
C564A 
(52% +/- 9% 
survival until adulthood) expressing flies at 25°C (Figure 4-6, G; data were averaged 
from three different experiment with 100 embryos each). Remarkably, GFP-LKB1
C564A
 
is able to rescue the lkb1-KO-mutant to almost the same extent as the wild type version. 
This suggests that farnesylation is not essential for LKB1’s physiological function and 
indicates that the lipid binding motif is more important for the function of LKB1 than 
farnesylation, but also not essential.  
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Figure 4-6 (page 70): The lipid binding domain is important, but not essential for 
the cortical localization and physiological function of LKB1. A-C – Rescued flies 
expressing GFP-LKB1ΔLB under control of the lkb1 promoter. A - Embryonic epithelium 
of a stage 12 embryo. B – NB of stage 10 embryo. C – Follicle cells surrounding the 
oocyte. D-F – Sagittal plane of embryonic epithelia expressing GFP-LKB1 constructs 
under control of the ubiquitin promoter, stage 9 (anterior region), lateral view. The wild 
type version is strictly localized to the cell cortex. G – Wild type GFP-LKB1 and 
farnesylation deficient GFP-LKB1C564A rescue the lethality of lkb1x5 at 25°C to a large 
extent, while only a small percentage of flies expressing the lipid binding mutant GFP-
LKB1ΔLB survive until adulthood. Error bars indicate SDs. Scale bars, 10 µm. 
 
4.2 Investigation of α-Spectrin and β-Spectrin as potential 
interaction partners of LKB1 
In a previous study (Krahn et al., so far unpublished) co-immunoprecipitation with 
GFP-LKB1 from embryonic lysates with subsequent identification of associated 
proteins by mass spectrometry has been used to identify potential interaction partners of 
LKB1. Among the candidate proteins that co-immunoprecipitated with GFP-LKB1 but 
not with GFP alone were α-Spectrin and β-Spectrin, which are components of the 
membrane skeleton in Drosophila (Dubreuil et al., 1997, Betschinger et al., 2005). 
Interestingly they are found at the basolateral cortex of epithelial cells, like LKB1.  
 
4.2.1 The lipid binding domain of LKB1 is also involved in binding of α/β-
Spectrin 
To verify the finding that GFP-LKB1 can co-immunoprecipitate α-Spectrin and β-
Spectrin, as identified by mass spectrometry in a previous work (Krahn et al., so far 
unpublished), embryonic lysates from rescued lkb1
x5
 fly lines were prepared and GFP-
LKB1 immunoprecipitated with the LKB1 antibody and Protein A sepharose beads. 
Both α-Spectrin and β-Spectrin were coimmunoprecipitated with GFP-LKB1 (Figure 4-
7, A). The same associations can be seen with the farnesylation deficient rescue 
construct, indicating that Spectrins could play a role in recruiting LKB1 independent of 
farnesylation. But with GFP-LKB1
ΔLB
 the association with the Spectrins appeared 
almost completely lost. This suggests that the lipid binding domain could also interact 
with Spectrins. 
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Figure 4-7: LKB1 interacts with Spectrins. A – GFP-LKB1 fusion proteins were 
immunoprecipitated from embryonic lysates of rescue lkb1x5 flies, bound proteins 
identified by Western blot analysis. B – Top view on follicle cell clone of α-Spectrin, 
which is identifiable by loss of α-Spectrin staining. GFP-LKB1C564A is still cortical. C – 
Cytoplasmic mislocalization of GFP-LKB1 in a β-Spectrin follicle cell clone, marked by 
loss of RFP. Top is apical. D – Embryonic epidermis of two embryos. The one in the 
top right corner has clearly detectable amount of β-Spectrin, the one on the left lacks a 
detectable β-Spectrin staining, but shows no loss of cortical localization of genomic 
GFP-LKB1. E – MBP-LKB1 binds directly to the N-terminus of β-Spectrin. MBP-LKB1, 
GST-β-Spectrin amino acids 1-281 and GST-β-Spectrin amino acids 410-850 were 
expressed in E. coli and purified. GST alone served as a negative control. F – Inputs 
for E are shown on a Coomassie-stained acrylamide gel. Scale bars, 10 µm. 
 
4.2.2 β-Spectrin is involved in lateral localization of LKB1 in follicle cells 
A potential role of Spectrin in targeting LKB1 to the cortex of polarized cell was 
investigated by genetic studies. Because of difficulties in staining the endogenous 
LKB1 in follicle cells, we used GFP-LKB1 expressing flies. In α-Spectrin mutant 
follicle cell clones, we did not observe a mislocalization of GFP-LKB1
C564A
, indicating 
that neither the farnesylation nor a potential binding to α-Spectrin are essential for 
targeting LKB1 to the cortex (Figure 4-7, A). In contrast, β-Spectrin follicle cell clones, 
marked by the loss of RFP, show a cytoplasmic mislocalization of GFP-LKB1 (Figure 
4-7, C). In embryos with a zygotic mutation of β-Spectrin, the epidermis of later 
embryonic stages (stage15-17) displays no detectable amount of β-Spectrin (Figure 4-7, 
D). Surprisingly, GFP-LKB1 is still correctly localized to the lateral membrane of these 
embryos.  
 
4.2.3 The N-terminus of β-Spectrin interacts with LKB1 
To identify which region of β-Spectrin binds to LKB1, pulldown experiments with 
purified recombinant LKB1 and recombinant fragments of β-Spectrin were performed. 
GST protein was used as a negative control. The β-Spectrin fragment containing amino 
acids 1-281, which includes the Calponin-homology domain, was able to bind MBP-
LKB1. The β-Spectrin fragment containing amino acids 410-850, which includes the 
first two Spectrin domains was not able to bind MBP-LKB1 (Figure 4-7, E). 
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4.3 Three NLS regulate nuclear localization of LKB1 
Although a GFP-LKB1
ΔLB
 did drastically reduce the cortical localization and viability 
of the flies compared to a wild type rescue construct (Figure 4-6), there were still adult 
survivors. This indicates that the cortical localization of LKB1 might not be essential 
for its function. Since many studies in mammalian cells did observe a nuclear 
localization and nuclear-cytoplasmic shuttling of LKB1 (Table 2-2), the nucleus might 
be the subcellular compartment in which LKB1 might perform its essential function for 
survival. This function might be executed by only a minor fraction of the total amount 
of LKB1, which is not observable by immunostaining.  
For an analysis of nuclear shuttling of LKB1 in Drosophila a Leptomycin B assay was 
performed on transiently transfected S2R+ cells expressing GFP-LKB1 constructs. 
Leptomycin B is an inhibitor for Exportin-1 (CRM1) and its Drosophila homolog 
embargoed, which are required for nuclear export of proteins containing a nuclear 
export signal (NES). The export of mammalian LKB1 by CRM1 has been described 
(Dorfman and Macara, 2008). As expected, Leptomycin B treatment of cells expressing 
a wild type version of GFP-LKB1 leads to a nuclear localization, indicating the 
presence of one or more nuclear localization signals (NLS) in the Drosophila LKB1 
(Figure 4-8, A). Predictions of potential NLS, for example with the “NLStradamus” 
program using a Hidden Markov Model for nuclear localization signal (NLS) prediction 
(Nguyen et al, 2009), yield three potential NLS in the sequence of Drosophila LKB1 
(Figure 4-8, E). Mutation of just the homolog region of the described NLS of 
mammalian LKB1 (Smith et al., 1999), termed GFP-LKB1
ΔNLS1
 did reduce, but not 
abolish the nuclear localization of LKB1 when treated with Leptomycin B (Figure 4-8, 
B). A construct with a combination of this mutation and one of one side of the polybasic 
motif at the C-terminus, which we have identified before to be important for nuclear 
localization of small C-terminal GFP-LKB1 constructs, did also have a nuclear 
localization (Figure 4-8, C). Finally, the mutation of all three predicted NLS lead to a 
complete loss of detectable nuclear GFP-LKB1 (Figure 4-8. D). The subcellular 
localization of GFP-LKB1
ΔNLS1-3 
expressed in wild type background showed an ectopic 
localization to apical cortex of the embryonic epithelium (Figure 4-9, A). In NBs, the 
cortical localization of this construct is not affected (Figure 4-9, A). 
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4.3.1 Nuclear localization supports fertility and embryonic survival 
To investigate the relevance of the three identified NLS in vivo, transgenic flies were 
created expressing mutant versions of GFP-LKB1 under control of the endogenous 
promoter. The single-NLS mutations of the first (GFP-LKB1
ΔNLS1)
, the second (GFP-
LKB1
ΔNLS2
) and a double mutant of the first and third NLS (GFP-LKB1
ΔNLS1,3
) could 
all rescue the lethality of the lkb1-KO allele lkb1
x5 
(three independent experiments with 
100 eggs for each genotype, resulting in a total number of 258, 243 and 254 fertilized 
eggs respectively, Figure 4-8, F).  
Young rescued flies expressing the triple-NLS mutant (GFP-LKB1
ΔNLS1-3
) displayed a 
high number of unfertilized eggs, identified by a white and soft appearance (~52% for 
GFP-LKB1
ΔNLS1-3 
compared to ~7% for GFP-LKB1
ΔNLS2
 and ~8% for GFP-
LKB1
ΔNLS1,3
, three independent experiments with 100 eggs for each genotype, Figure 4-
8, H). The fertilized eggs of the triple NLS mutant survived to a larger extent then the 
double mutant. Unlike in the previously mentioned set of experiments, all three 
displayed a L1 and L2 larval lethality (43%, 28% and 17% Figure 4-8, G). With 
collections from older flies however, there were still a number of unfertilized eggs of 
the triple mutant (Figure 4-8, J), but a remarkably high number of lethal embryos, as 
observed by a brown staining of the aged egg or a developed but not hatching embryo 
(~47 %), that was not observed in the embryos from collections of younger flies. 
 
4.3.2 Nuclear localization signals are involved in the activation of AMPK 
We performed a Western blot assay of embryonic lysates from recued lkb1
x5
 embryos 
using a phospho-specific antibody that detects phosphorylation of the LKB1 
phosphorylation site T172 on human AMPK and its counterpart in Drosophila (Cell 
Signaling Technology). The signal of phospho-AMPK in GFP-LKB1
ΔNLS1-3
 expressing 
embryos is remarkably lower than in embryos rescued by GFP-LKB1, GFP-LKB1
C564A
 
or GFP-LKB1
ΔLB
 (Figure 4-9 C), indicating a lower activity of GFP-LKB1
ΔNLS1-3
 
towards AMPK. 
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Figure 4-8: Three NLS control the nuclear localization of LKB1. A-D Transfected 
S2R+ expressing GFP-LKB1 constructs treated for 90 minutes with Leptomycin B. 
Note that all three NLS have to be mutated to lose the nuclear accumulation of LKB1. E 
– Schematic of the predicted NLS of LKB1, the amino acids which were mutated to 
disrupt the nuclear localization signal are indicated in red. F - GFP-LKB1ΔNLS1 , GFP-
LKB1ΔNLS2 and GFP-LKB1ΔNLS1,3 can rescue the lethality of lkb1x5. G - GFP-LKB1ΔNLS2 , 
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GFP-LKB1ΔNLS1,3 and GFP-LKB1ΔNLS1-3 can rescue the lethality of lkb1x5. H - In the same 
set of experiments that the diagram G displays, GFP-LKB1ΔNLS1-3 expressing flies show 
a high number of unfertilized eggs in comparison to GFP-LKB1ΔNLS2 and GFP-
LKB1ΔNLS1,3 expressing flies. I - GFP-LKB1ΔNLS1-3 expressing flies show a high number 
of lethal embryos. J - In the same set of experiments that the diagram I displays, the 
number of unfertilized eggs is highly variable. Error bars indicate SDs. Scale bars, 10 
µm. 
 
Figure 4-9: GFP-LKB1ΔNLS1-3 localizes to the apical surface of epithelial cells and 
displays a reduced activity towards AMPK. A,B – localization of genomic GFP-
LKB1ΔNLS1-3 expressed in wild type background. A - GFP-LKB1ΔNLS1-3 localization in 
embryonic epithelium is found on the basolateral, but also on the apical cortex and 
cytoplasmic, embryonic stage 12. B - GFP-LKB1ΔNLS1-3 localization in embryonic NB is 
predominantly cortical, embryonic stage 10. C – The comparison of GFP-LKB1, GFP-
LKB1C564A, GFP-LKB1ΔLB and GFP-LKB1ΔNLS1-3 activity estimated from phosphorylation 
status of the downstream kinase AMPK (anti-pAMPK T172 antibody) in a Western blot 
assay of lysates of rescued embryos displays a reduction of phospho-AMPK in GFP-
LKB1ΔNLS1-3 expressing flies. 80 µg lysate loaded for pAMPK blot, 15 µg loaded for 
Actin blot. Scale bars, 10 µm. 
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4.4 Effects of LKB1 overexpression 
 
4.4.1 LKB1 overexpression in embryonic neuroblasts and ubiquitous 
expression in the embryo lead to embryonic lethality independent 
of farnesylation, the lipid binding motif and kinase activity 
 
LKB1 has been described to be important for asymmetric cell division and spindle 
formation in larval NBs, were LKB1 is localization is diffuse cytoplasmic (Bonaccorsi 
et al., 2007 and Figure 4-2 E). To investigate whether a neuroblast-specific 
overexpression of GFP-LKB1 affects viability the UAS-GAL4  system was utilized.  
Furthermore we wanted to analyze, if the farnesyl-acceptor, the lipid binding site or the 
kinase activity are required for an effect. For this GFP-LKB1, GFP-LKB1
C564A
, GFP-
LKB1
ΔLB 
and the kinase dead GFP-LKB1
K201M 
were expressed driven by wor-GAL4. 
When expression was driven at 25°C, GFP-LKB1 increased the embryonic lethality, 
though the effect was not strong (33% +/- 22 % compared to 14% +/- 14% for GFP-
LKB1
C564A
 and 7% +/- 2% GFP-LKB1
K201M
, averaged from three independent 
experiments with a total number of 242, 270 and 262 embryos respectively; Figure 4-
10, A). Expression at 29°C, which increases the activity of the UAS-GAL4 system and 
thereby expression of the transgenes, lead to a significant embryonic lethality in all 
GFP-LKB1 construct investigated (42% +/- 13% for wild type GFP-LKB1, 29% +/-7% 
for GFP-LKB1
C564A
, 51% +/- 12% for GFP-LKB1
ΔLB
 and 49% +/- 8% for GFP-
LKB1
K201M
; Figure 4-10, B; three independent experiment with 100 embryos each were 
performed) suggesting that neither of the before mentioned mutations affect this 
phenotype significantly (p-value of a two tailed t-test assuming equal variances 
comparing the embryonic lethality of mutant and wild type counterpart is 0.27 for GFP-
LKB1
C564A
 , 0.54 for GFP-LKB1
ΔLB 
and 0.70 for GFP-LKB1
K201M
). 
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Figure 4-10: Overexpression of GFP-LKB1 in embryonic neuroblasts and 
ubiquitous expression in the embryo lead to embryonic lethality. A – At 25°C 
overexpression of wild type GFP-LKB1 increases embryonic lethality, but GFP-
LKB1C564A and GFP-LKB1K201M do not (data were averaged from three different 
experiment with 100 embryos each). B – At 29°C overexpression of GFP-LKB1, GFP-
LKB1C564A, GFP-LKB1K201M and GFP-LKB1ΔLB increase embryonic lethality (data were 
averaged from three different experiment with 100 embryos each). C – Expression of 
GFP-LKB1 under control of wor-GAL4 is hardly detectable in earlier stages of 
embryonic development (epithelium of stage 9 embryo). D – During late 
embryogenesis expression of GFP-LKB1 is clearly visible (dorsal view of frontal plane). 
E – GFP-LKB1, GFP-LKB1C564A, GFP-LKB1K201M and GFP-LKB1ΔLB expressed 
ubiquitously under control of dag-GAL4 lead to a high embryonic lethality. Almost all 
surviving larvae die (one experiment with 100 embryos for each genotype). F – 
Ubiquitous expression of GFP-LKB1 driven by daugtherless-GAL4 at 18°C. Error bars 
indicate SDs. Scale bars in C and D, 10 µm. Scale bar in F, 100 µm. 
The effect of LKB1 overexpression driven by the ubiquitous embryonic driver 
daughterless-GAL4 on the lethality was first examined at 25°C. Overexpression of 
GFP-LKB1 and the kinase dead GFP-LKB1
D317A
 at this temperature resulted in high 
embryonic lethality (4 of 280 GFP-LKB1 expressing embryos reached and died during 
larval stage 1, 271 embryos expressing GFP-LKB1
 D317A
 were embryonic lethal), almost 
all developed until late stages of embryonic development (as seen by the formation of 
jaws, not counted). To exclude non-kinase effects that might result from drastic 
overexpression, expression at 18°C has been analyzed for GFP-LKB1, GFP-LKB1
C564A
, 
GFP-LKB1
ΔLB 
and the kinase dead GFP-LKB1
K201M
. GFP-LKB1 driven by 
daughterless-GAL4 was still expressed at 18°C (Figure 4-10, F). In one experiment with 
100 embryos for each phenotype some embryos survived, but most were still embryonic 
lethal regardless of the mutation of LKB1 (68% of GFP-LKB1 expressing flies, 74% for 
GFP-LKB1
C564A
, 69% for GFP-LKB1
ΔLB 
and 72% for GFP-LKB1
K201M
), only sporadic 
animals survived larval stages (Figure 4-10, E).  
 
4.4.2 LKB1 overexpression leads to a slight reduction of eye size 
dependent on kinase activity  
LKB1 overexpression results in slight reduction of eye size and a weak rough eye 
phenotype (Wang et al, 2007), that is dramatically increased when it is co-
overexpressed with PAR-1 or Silnoon (Wang et al, 2007; Jang et al., 2008). The 
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peculiarity of this phenotype differs from an earlier study, were the overexpression of 
LKB1 alone has been reported to be sufficient for a significant reduction of eye size 
(Lee et al., 2006).  
 
Figure 4-11: LKB1 overexpression reduces eye size depending on kinase 
activity. A-F Adult male flies expressing GFP-LKB1 constructs under control gmr-
GAL4 at 25°C. G-K Adult male flies expressing GFP-LKB1 constructs driven by gmr-
fal4 at 29°C. 
To test whether the mutation of the farnesylation site, the lipid binding motif at the C-
termnius or the nuclear localization signals are critical for the regulation of eye 
development by LKB1, male flies expressing the recombinant proteins GFP-LKB1, 
GFP-LKB1
C564A
, GFP-LKB1
ΔLB
, GFP-LKB1
ΔNLS1
, GFP-LKB1
ΔNLS1,3, 
and GFP-
LKB1
ΔNLS1-3
 were generated using the UAS-GAL4 system. GFP-LKB1
KD
 (mutation 
K201M, kinase dead) was used as a negative control. As previously described, GFP-
LKB1 overexpression lead to a reduction of eye size and a rough eye phenotype (Figure 
4-11 A), while GFP-LKB1
KD
 expressing flies had a wild type appearance (Figure 4-11 
C). The phenotype of male flies that developed at 25°C appears almost identical in all 
investigated mutant versions except GFP-LKB1
KD
, indicating that the kinase activity of 
LKB1 is necessary for this phenotype (Figure 4-11 A-F). To increase the expression 
level flies were kept at 29°C. Since gmr-gal4 flies have an irregular eye development at 
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29°C, they were used as a negative control in this experiment. Since no obvious 
difference to flies expressing the recombinant GFP-LKB1 has been observed, the 
successive generation of flies carrying GFP-LKB1, GFP-LKB1
C564A
, GFP-LKB1
ΔLB
 
and GFP-LKB1
ΔNLS1-3
 heterozygously driven by gmr-gal4 were again kept at 29°C and 
male flies with the most severe phenotype (assumed to carry to copies of the UAS-
transgene) were imaged, but the peculiarity of the phenotype was not much stronger 
than at 25°C (Figure 4-11 G-K).  
 
4.4.3 The reduction of wing size is minimized in the triple NLS mutant  
Another organ in which LKB1 has been reported to negatively regulate size by inducing 
apoptosis is the Drosophila wing (Lee et al., 2006). To test whether nuclear localization 
of LKB1 is involved in this process, GFP-LKB1 and GFP-LKB1
ΔNLS1-3
 were expressed 
in the posterior of the wing disc driven by engrailed-GAL4. The homozygous driver line 
was thought as a negative control. Wings of adult male flies were imaged by transmitted 
light microscopy (Figure 4-12, A-D). 
The ratio of anterior to posterior area of the adult wings of males expressing GAL4, 
GFP-LKB1 or GFP-LKB1
ΔNLS1-3
 was calculated (Figure 4-12, E). As expected, this 
ratio was higher in flies expressing GFP-LKB1 constructs (anterior area/posterior area 
ratio of engrailed-GAL4 homozygous flies was 0.83 +/- 0.03, in GFP-LKB1 expressing 
flies 1.02 +/- 0.09 and 0.88 +/- 0.03 in GFP-LKB1
ΔNLS1-3
 expressing flies), indicating a 
reduction of the posterior compartment by overexpression of LKB1. Since this ratio is 
significantly reduced in GFP-LKB1
ΔNLS1-3
 compared to GFP-LKB1 expressing flies, the 
negative effect of LKB1 on organ size in the posterior compartment is reduced in GFP-
LKB1
ΔNLS1-3 
expressing flies, suggesting a role of the nuclear localization of LKB1 in 
apoptosis. These differences were significant (p value of two tailed t-test assuming 
equal variances engrailed-GAL4/GFP-LKB1: 9.6 x 10
-11
, engrailed-GAL4/GFP-
LKB1
ΔNLS1-3
: 4.4 x 10
-6
 and GFP-LKB1/GFP-LKB1
ΔNLS1-3
: 5.8 x 10
-7
).  
The homozygous driver line displayed a reduced total wing area compared to the other 
fly strains (Figure 4-12 D) and displayed no or two rudimentary cross veins instead of 
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one connecting longitudinal veins 3 and 4 (Figure 4-12, A), indicating a non-wild type 
phenotype.  
Imaginal discs of L3 larvae were dissected, stained with immunofluorescence and 
subjected to a TUNEL assay to detect apoptotic cells (Figure 4-12, F). The TUNEL 
staining had a high background signal; in most cases the whole wing disc was stained.  
 
Figure 4-12: The “reduction of wing size”-phenotype by LKB1 overexpression is 
reduced in GFP-LKB1ΔNLS1-3. A-C Transmitted light microscopic images of 
representative wings of male flies with the indicated genotype. A – Expression of GAL4 
under control of the engrailed promoter in the homozygous driver line leads to defect of 
the anterior cross vein. Arrows indicate the position of two rudimentary cross veins 
instead of one connecting the longitudinal veins 3 and 4. D – Overlay of the 
representative wings of A-C indicated by different colors. E – The posterior 
compartment of flies expressing GFP-LKB1ΔNLS1-3 driven by engrailed-GAL4 is larger 
than in flies expressing its wild type counterpart, as indicated by a reduced ratio of 
anterior to posterior compartment (n= 21 for en::GAL4 (homozygous), n=20 for GFP-
LKB1ΔNLS1-3, n=21 for GFP-LKB1). F – A TUNEL assay of an imaginal disc 
expressing GFP-LKB1 driven by engrailed-GAL4 indicates a weak increase in the 
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number of apoptotic cells in the posterior compartment but display a strong background 
signal. The arrowhead in A indicates the part of the wing that was not measured for the 
calculation of areas for E and F. Error bars indicate SDs. Scale bar in D, 1 mm. Scale 
bar in F, 100 µm.  
 
4.5 Examination of phosphospecific antibodies against LKB1  
The ability of mammalian LKB1 to autophosphorylate can be used to estimate its 
activity (Baas et al., 2003).To investigate the activity of Drosophila LKB1 in tissues by 
immunofluorescence and for use in Western blot analysis phosphospecific antibodies 
were produced, which should detect the phosphorylated autophosphorylation sites T312 
or T460 of Drosophila LKB1. However, both investigated pairs of antibodies did show 
a strong staining even in embryos which lack detectable amounts of LKB1 because of 
MTD-GAL4 driven RNAi knockdown of LKB1 (like described in 4.1.1). 
In a Western blot analysis of embryonic lysates of flies rescued by different GFP-LKB1 
constructs and a wild type control, the antibody against LKB1 phosphorylated at T460 
displays at least three bands (Figure 4-14). Since these bands are also present in the 
negative control, only the band below 70 kDa might be specific for LKB1 (the size of 
Drosophila LKB1 is 67 kDa). This would mean that GFP-LKB1 is degraded and LKB1 
can be detected in the rescued flies. A potential band of GFP-LKB1 at about 104 kDa, 
however, is not seen.    
Figure 4-13: The analyzed phosphospecific antibodies are not specific for LKB1 
in an immunofluorescence assay. A – Embryonic epidermis of wild type embryo 
expressing LKB1. Endogenous LKB1 is stained by the anti-LKB1 antibody described in 
4.1.1. B, C Both phosphorylation-specific antibodies against LKB1 display a strong 
staining even in the absence of detectable amounts of LKB1 in the epithelium of 
embryos in which LKB1 expression is knocked down by MTD-GAL4 driven RNAi. 
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Figure 4-14: The phosphospecific antibody against LKB1 pT460 is not specific. 
Western Blot of embryonic lysates of flies rescued by the expression of the indicated 
GFP-LKB1 construct and wild type flies (right lane). Arrows indicate the position of 
three bands present in the rescued fly lines as well as in the wild type. 
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5 Discussion 
 
LKB1 has caught a lot of attention since its discovery as the gene mutated in most cases 
of Peutz-Jeghers syndrome and its function as a tumor suppressor gene mutated in 
various types of cancer. While the role of LKB1 in energy sensing as part of the LKB1-
AMPK/mTOR pathway has been studied extensively, its role as a polarity regulator has 
been investigated less often. This might be caused by the fact that the involvement of 
LKB1 in epithelial cell polarity is often not obvious in vertebrate cell lines and in 
mutant mice (Sebbagh et al., 2011). A study on Drosophila embryos, on the other hand, 
indicates that loss of either AMPK or LKB1 causes similar defects in epithelial cells 
and a constitutively active form of AMPK is able to decrease the epithelial polarity 
defect of lkb-1 null mutant embryos (Lee et al., 2007). AMPK has also been suggested 
to regulate cell polarity in response to LKB1 signaling in mammalian cells (Nakano and 
Takashima, 2012). Remarkably, the activation of AMPK can occur by multiple 
pathways. For example, it can be activated by alternative kinases like Ca
2+
/calmodulin-
dependent protein kinase β (Hurley et al., 2005) or TGFβ-acivated kinase-1 (Xie et al., 
2006), which probably contribute to some effects attributed to the LKB1 complex. 
Though all members of the AMPK-like kinase family and some other proteins have 
been identified to interact with LKB1, functional consequences of these interactions 
remain unclear.  
In this work, the interactions of two new potential interaction partners of LKB1, α-
Spectrin and β-Spectrin, have been investigated. β-Spectrin was identified as a regulator 
of cortical localization of LKB1 in the follicle cell epithelium. Additionally, several 
other factors involved in subcellular localization of LKB1 were analyzed. These are of 
interest because the regulation of the specific activity of LKB1 towards downstream 
targets is probably mediated by its localization rather than activation by upstream 
regulators, which could not yet be identified (Sebbagh et al., 2011). Furthermore, the 
physiological relevance of the farnesylation motif, a lipid binding motif, nuclear 
localization signals and the kinase activity of LKB1 were investigated. 
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5.1 Cortical localization of LKB1 
 
5.1.1 LKB1 localizes to the cortex of epithelial cells and embryonic 
neuroblasts 
The specific activity of a kinase inside a cell can be regulated either by directly 
influencing its enzymatic activity or by targeting it to certain subcellular compartments. 
Most overexpression studies on mammalian cell lines describe a nuclear localization of 
LKB1, while endogenous levels of mammalian LKB1 have been studied in just a small 
number of studies. Surprisingly, in these studies LKB1 was not found in the nucleus, 
but in the cytosol and membrane fractions (Denison et al., 2009: Sebbagh et al., 2009). 
GFP-tagged LKB1 has been observed to localize to the cortex of female germ line cells 
and to the lateral membrane in follicle epithelia cells of Drosophila (Martin and St 
Johnston, 2003). In embryonic epithelial cells and embryonic neuronal stem cells 
(neuroblasts, NBs) overexpressed GFP-LKB1 was found along the cell cortex 
(Yamamoto et al., 2008), while the localization of endogenous LKB1 has not yet been 
described in these cell types. Endogenous Drosophila LKB1 has barely been studied, 
due to lack of an obtainable antibody (Yamamoto et al., 2008). In NBs of Drosophila 
larvae, immunostaining for LKB1 was found diffuse in the cytoplasm (Bonaccorsi et al., 
2007). It has also been observed at the subapical and basolateral membrane of the wing 
disc epithelium (Jang et al., 2008). 
To investigate the subcellular localization of LKB1 in Drosophila we raised an antibody 
that could detect endogenous LKB1 at the basolateral cortex of the embryonic 
epithelium and in the cortex of embryonic NBs and therefore displayed a localization 
that is in accordance with the localization of overexpressed GFP-LKB1 (Figure 4-2, A-
D and Yamamoto et al, 2008). In polarized MDCK cells endogenous mammalian LKB1 
has been described to colocalize with the adherens junction marker E-Cadherin instead 
(Sebbagh et al., 2009). LKB1 is present in the early stages of embryonic development, 
indicating a maternal distribution, which has been assumed from genetic studies (Martin 
and St Johnston, 2003). Surprisingly, but in accordance with the previously described 
localization in larval NBs (Bonaccorsi et al., 2007), a cytoplasmic localization of LKB1 
in this cell type was observed (Figure 4-2, E). This difference between larval and 
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embryonic NBs might reflect differences in their polarity regulation and mechanisms of 
asymmetric division. A similar localization is described for the transcription factor 
Prospero, which is localized to the cortex of embryonic but not larval NBs (Ceron et al., 
2001).  
 
5.1.2 Farnesylation is not crucial for the cortical localization of LKB1 and 
its physiological function 
Since the upstream regulation of LKB1 remains unknown, it has been proposed that 
LKB1 activity is mediated by its localization rather than activation by an upstream 
regulator (Sebbagh et al., 2011). Posttranslational modifications mediate the localization 
of many proteins. One such modification is farnesylation of a C-terminal CAAX motif. 
A CAAX motif consists of an invariant farnesyl acceptor cysteine (C), A is usually, but 
not always, an aliphatic amino acid and X is a variable amino acid. The C-terminal 
CAAX motif of LKB1, which is conserved in most model animals except C. elegans, 
has been reported to be involved in the localization of LKB1 in the Drosophila oocyte 
(Martin and St Johnston, 2003). A recently published study investigated farnesylation of 
endogenous LKB1 in mice using a farnesylation specific antibody reports that the 
majority of LKB1 is farnesylated (Houde et al., 2014). The farnesylation has not been 
proven directly in Drosophila, but conservation of the CAAX motif and the effect on 
cortical targeting in the oocyte (Martin and St Johnston, 2003) strongly suggests its 
occurrence.  
A farnesylation deficient mutation of LKB1 (GFP-LKB1
C564A
) had surprisingly little 
effect on the cortical localization in all tissues investigated, although the localization to 
the cortex appears weaker (Figure 4-3, A-F). This suggests that there are other factors 
apart from farnesylation that contribute to the cortical localization of LKB1. 
Furthermore, the fact that lethality of flies can be rescued to almost the same extent by 
the farnesylation deficient GFP-LKB1
C564A
 compared to its wild type counterpart 
indicates that farnesylation is not essential for its physiological function (Figure 4-6, G). 
It might however be essential in certain physiological conditions that have not been 
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investigated. Similarly, mice with a knockin of farnesylation deficient LKB1 did not 
display an overt phenotype (Houde et al., 2014). 
 
5.1.3 Both farnesylation and a polybasic motif target LKB1 to the plasma 
membrane 
S2R+ cells were used as a model system for plasma membrane targeting. These cells are 
not polarized and do not express transmembrane proteins like DE-Cadherin and 
Crumbs, making them an ideal model for analysis of plasma membrane targeting 
(Krahn et al., 2010). Since S2R+ cell also express abundant amounts of Spectrin 
(Dubreuil and Yu, 1994), they have also been used extensively to study interactions 
with the membrane skeleton. Most studies on LKB1 focused on overexpressed of LKB1 
in mammalian cell cultures, where it is mostly localized to the nucleus if no cofactors 
are co-overexpressed (Table 2-2). GFP-tagged Drosophila LKB1 however displayed a 
clear cortical localization in S2R+ cells. If the nuclear export mechanism for LKB1 is 
conserved in Drosophila, this suggesting that these cells express enough cofactors for 
the nuclear export of LKB1.  
Farnesylation was observed to be necessary for membrane localization of LKB1 in 
S2R+ cells, but the farnesylation motif was not sufficient to target GFP to the 
membrane (Figure 4-5 B and C). It is known that farnesylation is generally not 
sufficient for stable membrane targeting; this requires a second signal, usually a 
palmitoylation or the presence of a polybasic domain (Zhang and Casey, 1996). In this 
work, a polybasic motif at the C-terminus, which is involved in membrane targeting of 
LKB1, was identified. A lipid overlay assay revealed a direct binding of this motif to 
certain phospholipids in vitro. Of these, phosphatidylinositol-4,5-bisphosphate 
(PtdIns(4,5)P2, PIP2) has been reported to localize to the apical membrane of polarizing 
MDCK cells and proposed to be a determinant of apical identity (Martin-Belmonte and 
Mostov, 2007), which is surprising given the observed localization of LKB1. The 
binding of PIP2 was apparently not weaker in the lipid binding mutant, suggesting the 
presence of other lipid interaction motifs. Another bound lipid was 
phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3, PIP3), which has been 
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reported to be restricted to and to regulate formation of the basolateral plasma 
membrane of polarized epithelia (Gassam-Diagne et al., 2006). Furthermore, 
phosphatidic acid (PA) was bound, which is known to localize cytosolic proteins to 
membranes (Jang et al., 2009). Finally, phosphatidylinositol-5-phosphate (PtdIns(5)P) 
was identified, which is known as a signaling molecule in both the nucleus and the 
cytoplasm (Shisheva, 2013). As PIP-strips provide a two dimensional surface, they 
might not reflect lipid binding in vivo. A more precise model for protein-lipid 
interactions are membrane floatation assays utilizing liposomes (Krahn et al., 2010). 
The interaction of LKB1 with phospholipids has not been described before. A deficit of 
PIP2 in the plasma membrane created by the absence of the phosphatidylinositol-4-
phophate 5-kinase (PIP5K) Skittles, does not remove GFP-LKB1 from the oocyte 
cortex of Drosophila but delocalizes Bazooka (Gervais et al., 2008). In a similar manner 
the role of the other phospholipids in cortical localization could be investigated. Which 
of the potential interactions are relevant for LKB1 localization or signaling remains to 
be answered, but the membrane localization properties of phosphatidic acid and the 
basolateral localization of PIP3 match with the observed localization of LKB1. GFP-
LKB1
ΔLB
 could not rescue lkb1-KO flies to the same extent as its wild type or its 
farnesylation deficient counterpart, indicating a physiological relevance of this motif, 
though it is not absolutely essential under the given circumstances.  
Farnesylation might facilitate the initial targeting of LKB1 to the plasma membrane, but 
for a more stable localization a polar interaction with the head groups of phospholipids 
in the polybasic motif could be necessary. Though GFP-LKB1
ΔLB
 is mislocalized in 
overexpressing S2R+ cells and in other tissues when expressed under the control of the 
endogenous promoter, it can still localize to the cortex of the embryonic epithelium in a 
weak overexpression setting (Figure 4-6, F). The question remains open whether both 
the farnesylation motif and the lipid binding motif are sufficient for the cortical 
localization of LKB1. It will be necessary to investigate if a combination of both the 
farnesylation- and the lipid binding motif mutations abolishes cortical localization 
completely. 
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5.1.4 β-Spectrin is involved in lateral localization of LKB1 in follicle cells 
The fact that farnesylation-deficient LKB1 localizes remarkably similar in most 
polarized cells investigated indicates that a redundant mechanism for targeting LKB1 to 
the cortex exists. One possibility would be a direct binding of the lipid binding domain 
to phospholipids; another possibility would be an interaction with other cortically 
localized proteins or membrane-associated proteins.  
Spectrins are known to be important for crosslinking multiple proteins and membrane 
lipids. A colocalization of LKB1 with Spectrin in the basolateral cortex of embryonic 
epithelial cells was observed. Furthermore a co-immunoprecipitation assay verified the 
interaction of LKB1 and α-Spectrin and β-Spectrin. Whether LKB1 binds to either one 
of them or to a complex of both in embryonic lysates is not known. Other factors, like 
other proteins and lipids could also influence binding under these conditions. The 
interaction was depended on the presence of the lipid binding motif at the C-terminus of 
LKB1. This positively charged motif could thus function both in targeting LKB1 to the 
membrane, by interacting with the negatively charged head groups of phospholipids, as 
well as to Spectrin in the membrane skeleton. Notably, this interaction could not be 
observed when using a Triton X-100 containing buffer, which is likely disrupting polar 
interactions (Koley and Bard, 2010).  
Furthermore, in β-Spectrin mutant follicle cells we observed a loss of lateral localization 
of GFP-LKB1. It should be noted though that there is also a loss of the GFP-LKB1 
staining apically of the follicle cells in this picture (Figure 4-7, C), which is normally 
also located at the cortex of the oocyte and should not be affected by follicle cell 
mutants. This could indicate a so-called “false clone” (Haack et al., 2013), resulting 
from damage of the follicle cell epithelium, but we also observed a mislocalization of 
GFP-LKB1 in several other follicle cell epithelia, which were not positioned for 
imaging in median optical sections. Since the fixation took place before disruption of 
the ovarioles (like recommended for avoiding these artifacts in Haack et al., 2013), it 
seems unlikely to be an artifact. A safer approach is the direct staining of the product of 
the homozygous mutant gene, like performed for α-Spectrin follicle cell clones, which 
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did not affect localization of LKB1. α-Spectrin and β-Spectrin are generally thought to 
form heterotetrameric complexes, but β-Spectrin can accumulate independently of α-
Spectrin in S2 cells (Dubreuil et al., 1994). It has also been shown, that loss of β-
Spectrin in imaginal discs also reduces the level of α-Spectrin expression, but not vice 
versa (Hülsmeier et al., 2007). It is thus not astonishing that β-Spectrin can localize in 
the absence of α-Spectrin and interacts with LKB1 independent of α-Spectrin. 
Remarkably, in embryonic epithelia lacking detectable amount of β-Spectrin GFP-
LKB1 still localized cortically. The follicle cell epithelium and the embryonic epidermis 
might have different compositions of their lateral membrane domains, which could 
cause this difference. While the follicle cell epithelium is a secondary epithelium 
derived from mesodermal cells of the mother, the embryonic epithelium is a primary 
epithelium and thus they differ in some aspects of their cell polarity (Johnston and 
Ahringer, 2010). Maybe the embryonic epithelium has a higher content of 
phospholipids targeting LKB1 to the cortex independent of the presence of β-Spectrin. 
Furthermore, the N-terminus of β-Spectrin (containing the actin-binding Calponin-
homology domain) interacts with LKB1 in vitro. Because of technical difficulties only 
two fragments of β-Spectrin were purified and tested. There could therefore be other 
domains of β-Spectrin involved in binding of LKB1. The spectrin repeats are known to 
be involved in binding of peripheral membrane proteins. Human βI-Spectrin, for 
example, is known to interact with the basic motifs of the peripheral membrane ankyrin 
through electrostatic and hydrophobic interactions in the Spectrin repeats 14 and 15 
(Ipsaro and Mondragón, 2010). Whether the interaction of LKB1 and β-Spectrin is also 
caused by a polar interaction, possibly with the polybasic motif of LKB1 at the C-
terminus, remains to be investigated. 
 
5.1.5 A functional role of LKB1 membrane localization 
The lipid binding mutant GFP-LKB1 could not rescue the lethality of the lkb1
x5
 allele to 
the same extent as a farnesylation deficient or its wild type counterpart and had a 
reduced but probably not a complete loss of membrane localization. Under certain 
physiological conditions the membrane binding might be essential for the function 
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LKB1. Genetic and in vitro experiments suggest a phosphorylation and possible 
activation of LKB1 by PAR-1 (Martin and St Johnston, 2003), which is, like LKB1, 
present at the basolateral cortex (Shulman et al., 2000; Cox et al., 2000). The membrane 
localization of LKB1 might thus be necessary for a localized activation of LKB1. This 
could be investigated by finding the specific phosphorylation site of this kinase and 
investigating the localization of a phosphorylation-specific antibody. Another kinase 
that could regulate LKB1 is aPKC, the Drosophila homolog of PKCζ, which has been 
reported to phosphorylate LKB1 resulting in an export of nuclear LKB1 and hence 
AMPK activation (Xie et al., 2008). aPKC has been described to localize to the apical 
cortex (Chabu and Doe, 2008), where it might phosphorylate and thereby exclude 
LKB1 from the apical cortex, like it does exclude Lgl (Betschinger et al., 2003). 
Another role of LKB1 membrane targeting might be the co-localization with its 
substrates. AMPK has been described to be myristoylated (Mitchelhill et al., 1997; 
Oakhill et al., 2010), which also leads to membrane localization. Another cortical 
protein that has been shown to be phosphorylated by LKB1 is PAR-1 (Lizcano et al., 
2004), they might thus phosphorylate each other. Furthermore, interactions with 
phospholipids of the membrane might target LKB1 to certain membrane microdomains 
and control its activity. Elucidation of this potential regulation might explain how LKB1 
can be a context and tissue-specific kinase (Hermann et al., 2011). 
 
5.2 Three NLS regulate nuclear localization of LKB1 
The fact that GFP-LKB1 expressed in S2R+ cells is not localized to the nucleus 
suggests, if the nuclear export mechanism of LKB1 is conserved in Drosophila, that 
these cells express enough of the STRAD homolog Ste20-like kinase (Stlk) to export 
LKB1 from the nucleus. Since Stlk lacks key residues for kinase activity (Anamika et 
al., 2009), it can be assumed that it is a pseudokinase with no enzymatic activity but a 
regulatory function. The fact that Stlk co-iummoprecipitates with LKB1 (Krahn et al., 
so far unpublished) further indicates a conservation of its interaction with LKB1. 
Remarkably, a GFP-LKB1 with a phosphodeficient mutation of the conserved PKA 
phosphorylation site (S562) did not alter the localization, contradicting an importance of 
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this site for the nuclear export of LKB1 that has been proposed for mammalian LKB1 
(Xie et al., 2008).  
Nuclear-cytoplasmic shuttling of mammalian LKB1 has been studied intensively (Table 
2-2), the nuclear accumulation of LKB1 is thought to be driven by a NLS in the N-
teminal noncatalytic region (Nezu et al., 1999; Smith et al., 1999; Tianinen et al., 2002). 
Three NLS of Drosophila LKB1 have been identified in this study, using a Leptomycin 
B assay in S2R+ cells. Mutation of all three nuclear localization signals lead to a high 
number of unfertilized eggs and embryonic lethality in rescued flies, but the phenotype 
appeared to be dependent on the age of the parents. Since LKB1 is described to be 
essential for spermatogenesis in mice (Denison et al., 2011) the high number of 
unfertilized eggs might be caused by infertile males. In line with this, we had problems 
creating this fly stock because of infertile males and suspected a dominant negative 
phenotype. The triple NLS mutant protein GFP-LKB1
ΔNLS1-3 
does ectopically localize to 
the apical membrane in the embryonic epithelium. This might reflect a different 
interaction with other components involved in localization of LKB1 apart from the 
nuclear import machinery.  
 
5.3 Effect on mutations of LKB1 on AMPK activity  
AMPK has been described to regulate cell polarity under energetic stress conditions in 
response to LKB1 (Lee et al., 2007). In gastrointestinal mouse tissues, an antibody 
against AMPK phosphorylated at T172 (the site of phosphorylation by LKB1) displayed 
a localization to mitotic spindle poles, but in LKB1 mutant intestinal tissues phospho-
AMPK was mislocalized to the cell cortex of mitotic cells (Wei et al., 2012). LKB1 
might thus be responsible for the localization of AMPK in mitotic cells. 
Neither the farnesylation motif, the lipid binding motif nor the NLSs are essential for 
the function for LKB1 under the investigated circumstances, since mutant GFP-LKB1 
construct of either one could rescue the lethality of the lkb1
x5
 allele to some extent. 
Nevertheless, each might be essential under certain physiological conditions, like 
energetic stress.  
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In this study the basal activity of AMPK in embryos rescued by GFP-LKB1 constructs 
was analyzed. The basal level of AMPK phosphorylation does not seem to be affected 
in the farnesylation-deficient mutant, which differs from recent observations in mouse 
tissues (Houde et al., 2014). In all examines tissues and cells taken from homozygous 
LKB1
C433S/C433S
 mice the basal as well as the induced level of AMPK activation was 
significantly reduced, while the activity of several AMPK-related kinases was not 
affected. This indicates that the farnesylation of LKB1 is required for the selective 
activation of AMPK in vivo. Interestingly, the endogenous immunoprecipitated mutant 
LKB1
C433S
 protein was able to phosphorylate a recombinant AMPK complex to the 
same extent as wild-type LKB1 (Houde et al., 2014), indicating that neither the kinase 
activity nor the direct interaction with AMPK are affected. It has therefore been 
proposed that the membrane association of LKB1 might promote activation of AMPK. 
AMPKβ1 and AMPKβ2 are known to be myristoylated (Mitchelhill et al., 1997; Oakhill 
et al., 2010) and might thus function to co-localize the AMPK complex and farnesylated 
LKB1 on a membrane surface. The C-terminus of LKB1 has been observed to be 
crucial for cell polarity and the AMPK pathway in mammals (Forcet et al., 2005), but 
for the lipid binding mutant of GFP-LKB1 we did not observe a reduction of LKB1 
kinase activity towards AMPK. The triple NLS mutant however did show a 
significantly reduced activity towards AMPK. Since one of the NLS (NLS2) is localized 
in the kinase domain of LKB1 it is questionable if the kinase activity of the triple NLS 
mutant is generally reduced. Therefore, an assay analyzing the kinase activity of GFP-
LKB1
ΔNLS2
 will be necessary.  
For the phospho-AMPK blot the total amount of protein in the lysate was used to adjust 
protein concentrations. Since the mutations might affect protein levels (for example by 
increasing degradation), a blot to assess the GFP-LKB1 concentration more directly 
would be favorably. If this reduction of kinase activity of LKB1
ΔNLS1-3
 is specific for 
AMPK could probably be analyzed by using LKBtide, a synthetic peptide derived from 
human NUAK2 protein commonly used to measure LKB1 activity and mass 
spectrometrical analysis. Furthermore, recombinant AMPK and immunoprecipitated 
GFP-LKB1 could be used to assess if the interaction of LKB1 and AMPK is directly 
affected, because the in vivo interaction might also depend on membrane targeting, like 
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proposed for LKB1 and AMPK in mice (Houde et al., 2014). Possibly we would see a 
greater difference in the effect of mutant and wild-type LKB1 on AMPK 
phosphorylation in embryos under energetic stress, where LKB1 and AMPK have been 
shown to interact to regulate epithelial polarity (Lee et al., 2007),  
 
5.4 Kinase dependent and independent effects of overexpression 
of LKB1 
In this work, an increase in embryonic lethality induced by overexpression of LKB1 in 
the embryonic nervous system was not significantly affected by mutation of the 
farnesylation motif or the lipid binding motif. Furthermore, even a kinase dead version 
had the same effect, indicating that this phenotype is independent of kinase activity of 
LKB1. It has been described, that LKB1 can recruit the GC kinase Fray and Mo25 to 
the cortex of embryonic NBs to regulate asymmetric divisions independent of kinase 
activity (Yamamoto et al., 2008). This presumably affects the development of the 
nervous system, leading to the observed lethality phenotype. If LKB1 and Mo25 or Fray 
interact at the cortex, it is surprising that even the lipid binding mutation, which results 
in low cortical localization levels of LKB1, has the same phenotype. Since the effect 
appeared at 29°C but apparently not at 25°C, it is probably dependent on a high 
expression rate of LKB1. The effect on asymmetric cell division was not further 
investigated because of difficulties in imaging the GFP-LKB1 expression in the NBs of 
early embryos. Ubiquitous overexpression in the embryo had a more dramatic effect, 
resulting in high embryonic lethality. Even at 18°C, a temperature at which the activity 
of the UAS-GAL4 transcription machinery is decreased, most animals die at embryonic 
or early larval stages independent of farnesylation, the C-terminal lipid binding motif 
and kinase activity. High maternal expression of GFP-LKB1 has been reported to result 
in abnormally shrunk embryos (Yamamotao et al., 2008), which I also observed at 
higher temperatures (not imaged) but not at 18°C. 
An effect of LKB1 overexpression that was found to be dependent of the kinase activity 
is a slight reduction of eye size and a weak rough eye phenotype (Wang et al, 2007), 
which is dramatically increased when LKB1 is co-overexpressed with PAR-1 or 
Silnoon (Wang et al, 2007; Jang et al., 2008). In an earlier study, the overexpression of 
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LKB1 alone did significantly reduce eye size (Lee et. 2006). I used the same 
combination of driver and promoter that was used in these three studies (gmr-GAL4 and 
UAST promoter) and observed the weak phenotype described in the Wang et al, 2007 
and Jang et al., 2008. These differences might be caused by different expression levels 
or differences in the LKB1 construct used causing a different activity of the protein 
(Martin and St Johnston 2003 for example used a 540 amino acid construct of LKB1 
compared to 567 amino acids in this study). The rough eye/reduced eye size phenotype 
of GFP-LKB1 overexpression was not significantly reduced when the farnesylation 
motif, the lipid binding motif or the three NLS were mutated. Since the triple NLS 
mutant had a probably reduced activity towards AMPK in embryonic lysates, it could 
be assumed that it would have a decreased eye phenotype as well or even appear like the 
kinase dead version. Maybe a difference of wild type and triple a mutant overexpression 
of LKB1 would be visible when PAR-1 or Silnoon would be co-overexpressed, 
increasing the severity of the phenotype. Scanning electron microscopy could be 
utilized to identify more subtle differences. Furthermore, the lack of a significant 
difference between wild type and triple NLS mutant LKB1 on eye development might 
be a result of reduction of LKB1 activity that is specific for AMPK. Neither knockdown 
of AMPK nor its co-overexpression with LKB1 affect the development of the eye 
significantly (Amin et al., 2009; Wang et al., 2007). Instead, polarity establishment and 
remodeling probably dependent on an array of targets including PAR-1 and other 
AMPK-like kinases (Amin et al., 2009). If just the phosphorylation of AMPK is 
affected by the triple NLS mutation it would thus probably not affect the eye phenotype. 
Wing size can be negatively regulated by overexpression of LKB1, which induces 
apoptosis in wing discs (Lee et al., 2006). The overexpression of wild type GFP-LKB1 
resulted in significantly smaller posterior wing compartments (as indicated by a higher 
ratio of anterior to posterior compartment), compared to its triple NLS counterpart, 
indicating a reduced induction of apoptosis by the latter. The apoptosis induced by 
LKB1 might thus be, at least partly, regulated by nuclear LKB1. The reduced phenotype 
could also be caused by a reduced catalytic activity of the triple NLS mutant, like the 
possibly reduced activity towards AMPK shown in embryonic lysates. The fact that the 
homozygous driver line displayed a reduced wing size and the loss of a crossvein 
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connecting to longitudinal veins compared to the LKB1 overexpressing flies is most 
likely an artifact resulting from GAL4 overexpression. An actual negative control 
would be the overexpression of GFP or a GFP-RNAi construct driven by engrailed-
GAL4. 
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7.3 Abbreviations 
 
ADP  adenosine diphosphate 
AICAR  AICA-riboside 
AMP  adenosine monophosphate 
AMPK  AMP-activated protein 
kinase 
aPKC  atypical protein kinase C 
ATM   Ataxia telangiectasia 
mutated 
ATP  adenosine triphosphate 
Baz  Bazooka 
BSA  bovine serum albumin 
Cdc37  Cell division cycle 37  
C. elegans Caenorhabditis elegans 
CHIP  carboxy terminus of 
Hsp70p-interacting protein 
CLIP-170 cytoplasmtic linker protein 
170 
CREB  cAMP response element-
binding protein 
CRTC2 CREB regulated 
transcription coactivator 2 
DAPI  4’, 6-diamide-2’-
phenylindole 
dihydrochloride 
Dbl   diffuse B-cell lymphoma 
DE-Cad DE-Cadherin 
DNA  deoxyribonucleic acid 
dNTP  deoxynucleotide 
triphsophate  
Dlg  Discs large 
Drosophila Drosophila melanogaster 
DTT  dithiothreitol 
E. coli  Escherichia coli 
FCC  Follicle cell clones 
FLP  Flipase 
FRT  Flipase recognition target 
sequence 
GAL4  GAL4 transcription factor 
GFP  green fluorescent protein 
GMC  ganglion mother cell 
GST  Gluthathione-S-transferase 
HRP  horse radish peroxidase  
Hsp90  heat shock protein 90  
Hsc70  heat shock cognate 70 
  
KD  kinase dead 
kDa  kilodalton 
KO  knockout 
LB  Lysogeny broth 
Lgl  Lethal (2) giant larvae 
LKB1  liver kinase B 1 
MBP  Maltose binding protein 
MDCK Madin-Darby canine kidney 
(cell line) 
Mir  Miranda 
Mo25  Mouse protein 25 
MRLC  myosin II regulatory light 
chain  
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Mst4  mammalian STE20-like 
protein kinase 4 
mTOR  mammalian target of 
rapamycin 
NADPH Nicotinamide adenine 
dinucleotide phosphate 
(reduced) 
NB   neuroblast 
NES   nuclear export signal 
NHS  normal horse serum 
NLS   nuclear localization signal 
ORF  open reading frame 
PA  phosphatidic acid 
PAGE  polyacrylamide gel 
electrophoresis 
PAR  Partioning defective 
PC  phosphatidylcholine 
PE  phosphatidyl-ethanolamine 
PCR  polymerase chain reaction 
PIP  phosphatidylinositol 
phosphate 
PIP2  phosphatidylinositol-4,5- 
bisphosphate  
PIP3   phosphatidylinositol-3,4,5- 
triphosphate 
PJS  Peutz-Jeghers-Syndrome 
PKA  Protein kinase A 
PtdInsP  phosphatidylinositol-
phosphate 
rpm  rotations per minute 
Scrib  Scribble 
S2  Schneider 2 
SD  standard deviation 
SDS  sodium dodecyl sulfate 
STRAD  STE-20-related adaptor 
STK11  Serine/threonine kinase 
  11 
Stlk  Ste20-like kinase 
TEMED tetramethylethylen-diamide 
TGFβ  Transforming growth factor 
β 
Tris  Trishydroxymethyl- 
aminomethane 
TUNEL TdT-mediated dUTP- 
biotin nick end labeling 
UAS  upstream activating 
sequence 
w  white 
 
